I010: Potentially high prevalence of primary aldosteronism in a general practice population in Tayside, Scotland. (Englisch)

In: American journal of hypertension   ;  12 ,  S4  ;  204A-a-  ;  1999

Wie erhalte ich diesen Titel?

Download
Kommerziell Vergütung an den Verlag: 30,18 € Grundgebühr: 4,00 € Gesamtpreis: 34,18 €
Akademisch Vergütung an den Verlag: 30,18 € Grundgebühr: 2,00 € Gesamtpreis: 32,18 €

Inhaltsverzeichnis – Band 12, Ausgabe S4

Zeige alle Jahrgänge und Ausgaben

Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.

1A
Cardiac microvascular changes in DOCA-salt hypertensive rats: effect of endothelin ETA receptor antagonism
Larouche, I. / Schiffrin, E.L. | 1999
1A-a
The effects of insulin on renin-angiotensin expression in human cultured vascular endothelial cells
Kamide, K. / Hori, M.T. / Barrett, J.D. / Eggena, P. / Tuck, M.L. | 1999
1A-b
Endothelin and cardiac natriuretic peptides in heart failure
Del Ry, S. / Andreassi, M.G. / Nardini, V. / Colombo, M.G. / Clerico, A. / Biagini, A. / Giannessi, D. | 1999
1A-c
Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils
de Frutos, T. / García-Durán, M. / Díaz-Recasens, J. / Gálvez, G. / Sánchez de Miguel, L. / Montón, M. / Rico, L. / Farré, J. / Romero, J. / Casado, S. et al. | 1999
2A
Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways
Touyz, R.M. / Schiffrin, E.L. | 1999
3A
Aggressive blood pressure control may eliminate racial disparity in hypertensive renal disease: the hypertension optimal treatment trial (hot study)
Jamerson, K. / Ojo, A. / Fierro, G. / Hall, D. / Lawton, W. / Rahman, N. / Ram, V. / Randall, O. / Shultz, P. / Steigerwalt, S. et al. | 1999
3A-a
Misoprostol effects on NSAID-induced cardiorenal changes (MEDIC study)
Munger, M.A. / Gardner, S.F. / Rabetoy, G.M. / Cheung, A.K. / Barri, Y.M. / MEDIC Study Investigators, | 1999
3A-b
Indomethacin increases BP in hypertensive patients controlled with an ace inhibitor
Morgan, T. / Anderson, A. / Bertram, D. / Jones, E. | 1999
3A-c
Rapid recovery of acute vasoconstrictor effect but delayed recovery of full hypertensive effect after single dose losartan in Ang II-infused conscious rats
Sealey, J.E. / Hu, L. / Catanzaro, D.F. / Laragh, J.H. | 1999
4A
Abnormal renal and humoral response to sodium in hypertensive patients with the CC-genotype of the angiotensin II type 1 receptor
Spiering, W. / Kroon, A.A. / Fuss-Lejeune, M.J.M.J. / Daemen, M.J.A.P. / de Leeuw, P.W. | 1999
4A-a
Relationship of angiotensin converting enzyme (ACE) gene polymorphism and salt-sensitivity in essential hypertension
Giner, V. / Poch, E. / Oriola, J. / Bragulat, E. / Gómez-Angelats, E. / Antonio, M.T. / Botey, A. / Coca, A. / de la Sierra, A. | 1999
4A-b
M235T polymorphism of the angiotensinogen gene and cardiovascular-renal risk
Kuznetsova, T. / Wang, J. / Emelianov, D. / Fagard, R. / Vlietinck, R. / Staessen, J.A. | 1999
4A-c
Angiotensinogen genotype affects HDL levels in afro-caribbeans
Robinson, M.T. / Grim, C.E. / Wilson, T.W. / Viswanathan, A. / Lifton, R.P. / Etienne, C. / Grell, G. / Grim, C.M. / Wilson, D.M. / Svahn, D.S. | 1999
5A
The maternal inheritance of hypertension among African Americans
Chung, A.B. / Doyle, J.P. / Wallace, D.C. / Hall, W.D. | 1999
5A-a
T344C aldosterone synthase gene polymorphism in low renin hypertension
Regolisti, G. / Rossi, E. / Casali, B. / Perazzoli, F. / Nicoli, D. / Negro, A. / Davoli, S. / Sani, C. / Farnetti, E. | 1999
6A
Genetic polymorphism of the renin-angiotensin-aldosterone system (RAAS) and organ damage (TOD) in essential hypertension (EH)
Pontremoli, R. / Viazzi, F. / Nicolella, C. / Ravera, M. / Berruti, V. / Leoncini, G. / Bezante, G.P. / Zagami, P. / Ravazzolo, R. / Deferrari, G. | 1999
6A-a
Parallelism between cardiac and vascular changes at different sites in the early phase of hypertension
Vaudo, G. / Schillaci, G. / Evangelista, F. / Pasqualini, L. / Verdecchia, P. / Mannarino, E. | 1999
6A-b
Determinants of left ventricular mass in French middle-aged male population
Thomas, F. / Benetos, A. / Ducimetière, P. / Guize, L. | 1999
6A-c
Hemodynamics of resistant hypertension in the current era
Taler, S.J. / Augustine, J. / Schwartz, L. / Textor, S.C. | 1999
7A
Abnormal prothrombotic factors and endothelial dysfunction in isolated systolic hypertension: implications for thrombogenesis and atherogenesis
Lip, GYH. / Blann, A.D. / Jones, A.F. / Beevers, D.G. | 1999
7A-a
p53 is not involved in the overexpression of bax protein in the left ventricle of SHR
Fortuño, M.A. / Zalba, G. / Fortuño, A. / Ravassa, S. / D'Lom, E. / Díez, J. | 1999
7A-b
Impaired synthesis of elastin during fetal and infant life as a cause of raised adult blood pressure
Martyn, C.N. / Greenwald, S.E. / Phillips, N. | 1999
7A-c
Defective suppression of aldosterone biosynthesis during stroke permissive diet in the stroke-prone SHR
Gigante, B. / De Paolis, P. / Porcellini, A. / Mele, A.F. / Savoia, C. / Russo, R. / Giliberti, R. / Enea, I. / Rubattu, S. / Ganten, D. et al. | 1999
8A
Elevated potassium concentration inhibits vascular smooth muscle cell proliferation in vitro
Ma, G. / Young, D.B. | 1999
8A-a
Eicosapentaenoic acid is a potent inhibitor of angiotensin II-induced calcium signals in vascular smooth muscle cells
Ormsby, B.L. / Hori, M.T. / Tuck, M.L. | 1999
8A-b
Src modulates Ang II-mediated Ca2+ signaling in human vascular smooth muscle cells
Touyz, R.M. / Wu, X-H. / Schiffrin, E.L. | 1999
8A-c
Tyrosine phosphorylation of human platelet plasma membrane Ca2+-ATPase in hypertension
Blankenship, K.A. / Dawson, C.B. / Aronoff, G.R. / Dean, W.L. | 1999
9A
The role of cyclosporine-A on apoptosis in human vascular smooth muscle cells
Seta, K. / Song, H. / McLaughlin, J.S. / Wei, C. | 1999
10A
Effects of chronic long term calcium-antagonists therapy on cytogenetic damage in humans
Andreassi, M.G. / Varga, A. / Del Ry, S. / Petrozzi, L. / Giannessi, D. / Picano, E. | 1999
10A-a
Importance of gender and age in assessing the 24-hour blood pressure response to antihypertensive therapy
White, W.B. / Johnson, M.F. / Fakouhi, T.D. / Oparil, S. / Sica, D.A. / Black, H.R. | 1999
10A-b
Sildenafil citrate: well-tolerated by patients with erectile dysfunction taking concomitant antihypertensive therapy
Prisant, Michael / Brown, Morris / Sildenafil Study Group, | 1999
10A-c
The ambulatory blood pressure monitoring and treatment of hypertension
Jinxiang, Xie / Lisheng, Liu / APTH Trial Group, | 1999
11A
Major cardiovascular events in long-term treated essential hypertensive patients: Calcium channel blockers (CCB) versus ACE inhibitors (ACEI)
Campo, C. / Segura, J. / Puras, A. / Alcázar, J.M. / Rodicio, J.L. / Ruilope, L.M. | 1999
12A
Combined effect of pulse pressure and heart rate on cardiovascular risk
Thomas, F. / Bean, K. / Morcet, J.F. / Dubanchet, A. / Guize, L. / Benetos, A. | 1999
12A-a
Pulse pressure is an independent predictor of microalbuminuria in non diabetic males
Pedrinelli, R. / Di Bello, V. / Dell'Omo, G. / Giorgi, D. / Bandinelli, S. / Penno, G. / Mariani, M. | 1999
12A-b
Pulse pressure - not mean pressure - determines cardiovascular risk in older hypertensive patients
Gasowski, J. / Blacher, J. / Staessen, J.A. / Girerd, X. / Thijs, L. / Liu, L. / Wang, J.G. / Fagard, R.H. / Safar, M.E. | 1999
12A-c
Pulse pressure: a predictor of cardiovascular mortality among young normotensive subjects
Fang, J. / Madhavan, S. / Alderman, M.H. | 1999
13A
Elevated serum uric acid levels are associated with increased hypertension morbidity in the minority population
San Diego, R. / Pan, D. / Morisky, D. / Enenmoh, A. / Fong, R. / Ward, H. | 1999
13A-a
Serum uric acid, its change with diuretic use and risk of cardiovascular events in the systolic hypertension in the elderly program (SHEP)
Franse, L.V. / Pahor, M. / Di Bari, M. / Shorr, R.I. / Wan, J.Y. / Somes, G.W. / Applegate, W.B. | 1999
14A
Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell
DePaolis, P. / Gigante, B. / Porcellini, A. / Mele, A. / Giliberti, R. / Lombardi, A. / Rubattu, S. / Volpe, M. | 1999
14A-a
Angiotensin II-Mediated apoptosis and P53 expression in human cardiomyocytes
Lau, P. / Kinjo, M. / Song, H. / Seta, K. / Downing, S.W. / Wei, C. | 1999
14A-b
Dual renin targeting by cre-mediated intercromatid recombination.
Matsusaka, T. / Takaya, J. / Katori, H. / Kon, V. / Fogo, A. / Ichikawa, I. | 1999
14A-c
No effect of beta-blockade on the secondary, heart rate-related increase in blood pressure caused by Ang II infusions in conscious rats
Hu, L. / Catanzaro, D.F. / Laragh, J.H. / Sealey, J.E. | 1999
15A
Selective aldosterone antagonist or adrenalectomy prevents L-name/ang II-induced renal injury in rats.
Rocha, R. / Stier, C.T. / Adler, G.K. / Kifor, I. / Mullen, D. / Williams, G.H. | 1999
16A
Long-term angiotensin AT1 receptor blockade with fonsartan increases lifespan of hypertensive rats
Linz, W. / Schölkens, B.A. / Heitsch, H. / Wiemer, G. | 1999
16A-a
Transfer of the Y chromosome from the brown norway rat into the SHR induces significant decreases in blood pressure.
Qi, N. / Kren, V. / Pravenec, M. / Zidek, V. / Krenova, D. / Kurtz, T.W. | 1999
16A-b
PST 2238 a new antihypertensive compound that modulates renal Na-KATPase in genetic hypertension.
Ferrari, P. / Ferrandi, M. / Torielli, L. / Duzzi, L. / Padoani, G. / Minotti, E. / Melloni, P. / Bianchi, G. | 1999
16A-c
Cardiac hypertrophy in the prague hypertensive rat (PHR) is associated with enhanced JNK2 but not ERK tissue activity
Vogel, V. / Bokemeyer, D. / Lindemann, M. / Schmandt, T. / Heller, J. / Kramer, H.J. | 1999
17A
Value of ambulatory BP versus office BP in predicting left ventricular mass index in untreated African-American hypertensives.
White, W.B. / Uwaifo, G.I. / Mansoor, G.A. / Giacco, S. / Suri, R. | 1999
17A-a
The interactive effect of body size and renin-angiotensin axis on blood pressure response to oral salt loading in normotensive African-Americans.
Holmes, C.B. / Staffileno, B.A. / Hamaty, M. / Dudley, A. / Yunis, C. / Grimm, R.H. / Flack, J.M. | 1999
17A-b
Ethnic differences in left ventricular geometry may be due to higher peripheral resistance and an attenuated nocturnal blood pressure decline in African-Americans.
Hinderliter, Alan L. / Waugh, Robert / Kisslo, Joseph / Sherwood, Andrew | 1999
17A-c
Impaired cognitive function in hypertensive patients with asymptomatic cerebral white matter lesions
Sierra, C. / de la Sierra, A. / Salamero, M. / Mercader, J.M. / Aguilera, M.T. / Antonio, M.T. / Gómez-Angelats, E. / Bragulat, E. / Giner, V. / Coca, A. | 1999
18A
Cerebral blood flow in asymptomatic hypertensive patients according to the presence of cerebral white matter lesions
Sierra, C. / de la Sierra, A. / Chamorro, A. / Mercader, J.M. / González, J. / Gómez-Angelats, E. / Antonio, M.T. / Aguilera, M.T. / Coca, A. | 1999
19A
Hypertension does not significantly alter abnormalities of haemorheology, endothelial dysfunction and thrombogenesis in acute stroke: the West birmingham stroke project.
Lip, G.Y.H. / Blann, A.D. / Farooqi, I.S. / Zarifis, J. / Beevers, D.G. | 1999
19A-a
Preactivated peripheral monocytes in hypertensive patients
Dörffel, Y. / Franz, S. / Scholze, S. / Lätsch, C. / Scholze, J. | 1999
20A
Comparison of insulin resistance, lipids, and body size between children with high and low blood pressure: Results from insulin clamp studies in 357 subjects
Sinaiko, A.R. / Steinberger, J. / Moran, A. / Luepker, R.V. / Prineas, R.J. / Rocchini, A.P. / Jacobs, D.R. | 1999
20A-a
Relationship between changes in indices of alcohol intake and blood pressure in the prevention and treatment of hypertension study (PATHS)
Cushman, W.C. / Bingham, S.F. / Hanna, E. / Cutler, J.A. / Kirk, G.F. / Lakshman, M.R. / Dufour, M. / PATHS Group, | 1999
20A-b
High sodium intake is associated with improved insulin sensitivity in sodium sensitive as compared with sodium resistant hypertension prone men
Melander, O. / Willsteen, G. / Groop, L. / Hulthén, U.L. | 1999
20A-c
Association of end tidal CO2 with rate of change in blood pressure over 20 years
Anderson, D.E. / Eyster, C. | 1999
21A
Prevention of preeclampsia with aspirin is dependant on bleeding time increase
Dumont, A. / Beaufils, M. / Flahaut, A. / Verdy, E. / Uzan, S. | 1999
22A
The effect of angiotensin II on human vascular smooth muscle cell apoptosis
Song, H. / Seta, K. / Wei, C. | 1999
22A-a
Selective induction of BCL-XS is a major determinant of vascular smooth muscle cell apoptosis
Igase, M. / Okura, T. / Kitami, Y. / Fukuoka, T. / Takata, Y. / Nakamura, M. / Hiwada, K. | 1999
22A-b
Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells
Wu, X-H / Touyz, R.M. / Schiffrin, E.L. | 1999
22A-c
Role of vasopressin in vascular remodeling of DOCA-salt-treated brattleboro rats.
Intengan, H.D. / Schiffrin, E.L. | 1999
23A
Effect of insulin on bradykinin-induced intracellular calcium mobilization in cultured human endothelial cells.
Takagawa, Y. / Hori, M.T. / Tuck, M.L. | 1999
23A-a
Cyclooxygenase-2 (cox-2) in the thick ascending limb: Regulation and function.
Ferreri, N.R. / An, S. / Cespedes, C. / McGiff, J.C. / Vio, C.P. | 1999
23A-b
Hyperphosphorylation and desensitization of the dopamine D1 receptor in renal proximal tubules in essential hypertension
Sanada, H. / Jose, P.A. / Xu, J. / Yu, P. / Hazen-Martin, D. / Carey, R.M. / Felder, R.A. | 1999
23A-c
Dose-related antihypertensive efficacy of omapatrilat, a vasopeptidase inhibitor, in models of normal and low renin hypertension
Burnett, J.C. / Powell, J.R. / Trippodo, N.C. / Omapatrilat Investigators, | 1999
24A
Intrarenal angiotensin levels in hypertensive rats with reduced renal mass
Mackie, F.E. / Campbell, D.J. / Meyer, T.W. | 1999
24A-a
Angiotensin II (AngII) activates nuclear factor-{kappa}B via AT1 and AT2 receptors in the kidney
Ruiz-Ortega, M. / Lorenzo, O. / Ruperez, M. / Egido, J. | 1999
25A
Self-treatment of hypertension with device-guided breathing exercises: a double-blind, randomized study
Schein, M. / Gavish, B. / Herz, M. / Rosner-Kahana, D. / Naveh, P. / Knishkowy, B. / Zlotnikov, E. / Ben-Zvi, N. / Melmed, R.N. | 1999
25A-a
Effect of supplemental calcium on the antihypertensive effectiveness of nifedipine in hypertensive patients
Lewanczuk, R.Z. / Toal, C.B. / on behalf of the Canadian Investigators., | 1999
25A-b
HeartstylesTM profiles: implications of health lifestyle analysis for improving hypertension control.
Weir, M.R. / Maibach, E.W. / Bakris, G.L. / Black, H.R. / Chawla, P. / Messerli, F.H. / Neutel, J.M. / Weber, M.A. | 1999
25A-c
Purified docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans -- a randomised controlled trial.
Mori, T.A. / Bao, D.Q. / Burke, V. / Puddey, I.B. / Beilin, L.J. | 1999
26A
Prevention of dementia in the systolic hypertension in Europe (Syst-Eur) trial
Forette, F. / Staessen, J.A. / Seux, M.L. / Thijs, L. / on bahalf of the Syst-Eur Investigators, | 1999
26A-a
Calcium antagonists and cardiovascular risk in patients with essential hypertension and non-insulin-dependent diabetes
Verdecchia, P. / Schillaci, G. / Borgioni, C. / Ciucci, A. / Porcellati, C. | 1999
26A-b
Evidence of confounding by indication: prescribing of calcium antagonists
Leader, S. / Roht, L. | 1999
26A-c
Monotherapy treatment success rate of omapatrilat, a vasopeptidase inhibitor, compared with lisinopril and amlodipine in mild to moderate hypertension
Black, H.R. / Chang, P.I. / Reeves, R.A. / Cooper, W. / Pouleur, H. / for Omapatrilat Investigators., | 1999
27A
Once-daily effects of the angiotensin receptor blocker, eprosartan on 24-hour blood pressure in patients with systemic hypertension
White, W.B. / Anis Anwar, Y. / Sica, D.A. / Dubb, J. | 1999
28A
Blood pressure response of hypertensive patients to fenoldopam is augmented in non-dippers
Sunthornyothin, S. / Pool, J.L. / Shepherd, A.M.M. / Taylor, A.A. | 1999
28A-a
The effects of hydrochlorothiazide and losartan on fibrinolytic function in normal subjects
Lottermoser, K. / Hertfelder, H.H. / Vetter, H. / Düsing, R. | 1999
28A-b
Comparison of the efficacy of zofenopril or enalapril in patients with mild to moderate hypertension
Giusti, A. / Bertolotti, M. / Llabres, S. / Carre, A. / Casini, A. | 1999
28A-c
Effect of chronic moxonidine therapy on peripheral sympathetic activity in essential hypertension
Greenwood, J.P. / Scott, E.M. / Mary, D.A.S.G. / Stoker, J.B. | 1999
29A
Autonomic balance is shifted toward increased vagal predominance during verapamil compared with amlodipine in patients with mild to moderate hypertension - the vamphyre study
Lefrandt, J.D. / Urbigkeit, A. / Sevre, K. / Castellano, M. / Hausberg, M. / Fallon, M. / Fluckiger, L. / Heitmann, J. / Rostrup, M. / Agabiti Rosei, E. et al. | 1999
29A-a
Effects of the addition of doxazosin to the anyihypertensive treatment in essential hypertensives with benign prostatic hypertrophy
Martell, N. / Fernández-Pinilla, C. / HBP&BPH, | 1999
29A-b
Randomized, prospective dose-comparability study of amlodipine or nifedipine gits in hypertension
Elliott, W.J. / Chrysant, S.G. / DeAbate, C.A. / Denker, F. / Rosansky, S. / Almas, M. / Nuttall, C. | 1999
30A
Increased renal vasodilatory effect of arachidonic acid in spontaneously hypertensive rats. Role of cytochrome P450 pathway
Pomposiello, S. / McGiff, J.C. | 1999
30A-a
Different effects of calcium channel blockers on renal damage development in the fawn-hooded hypertensive rat
Provoost, A.P / Van Dokkum, R.P.E. | 1999
31A
Conventional and ambulatory blood pressure as predictors of cardiovascular risk in older patients with systolic hypertension
Staessen, J.A. / Thijs, L. / Fagard, R. | 1999
31A-a
Do we undertreat hypertensive smokers. A comparison of 24H-ambulatory blood pressure monitoring.
Buttenschøn, T.L. / Bang, L.E. / Kristensen, K.S. / Svendsen, T.L. | 1999
31A-b
Physical activity as a determinant of diurnal blood pressure variation.
Kario, K. / Pickering, T.G. / Schwartz, J.E. | 1999
31A-c
Marital factors over 3 years influence blood pressure and left ventricular mass in mildly hypertensive patients
Baker, B. / Helmers, K. / Paquette, M. / O'Kelly, B. / Tobe, S. | 1999
32A
Augmentation of renal vasoconstrictor responses to norepinephrine and angiotensinii by leptin.
Osei, S.Y. / Ahima, R.S. / Coletti, C. / Krupinski, J. / Flier, J.S. / Hollenberg, N.K. | 1999
32A-a
Marked resistance of the ability of insulin to decrease wave reflection in the aorta characterizes human obesity
Westerbacka, J. / Vehkavaara, S. / Wilkinson, I. / Cockcroft, J. / Yki-Järvinen, H. | 1999
32A-b
High dietary NaCl intake unmasks a pressor effect of chronic intracerebroventricular administration of leptin.
Correia, M.L.G. / Morgan, D.A. / Sivitz, W.I. / Mark, A.L. / Haynes, W.G. | 1999
32A-c
Obesity, hypertension and weight gain-induced blood pressure elevation.
Masuo, K. / Mikami, H. / Ogihara, T. / Tuck, M.L. | 1999
33A
Impaired left ventricular diastolic function during isometric exercise in hypertensive diabetics with albuminuria despite negative stress test may suggest early subclinical myocardial ischaemia
Salmasi, A-M. / Kirollos, C. / Grenfell, A. / Jepson, E. / Dancy, M. | 1999
34A
Calcineurin inhibition does not prevent pressure-overload left ventricular hypertrophy in rat models.
Zhang, W. / Kowal, R.C. / Rusnak, F. / Sikkink, R.A. / Olson, E.N. / Victor, R.G. | 1999
34A-a
Regression of left ventricular hypertrophy on serial echocardiography in the hypertension optimal treatment study.
Amerena, J. / Zabalgoitia, M. / Rahman, Noor U. / Yarows, S. / Haley, W. / Lucas, C. / Yunis, C. / Krause, L. / Ombao, H. / Valentini, M.C. et al. | 1999
34A-b
24-hour ambulatory blood pressure in patients with ECG determined left ventricular hypertrophy: the life study.
Wiinberg, N. / Bang, L.E. / Wachtell, K. / Olsen, M.H. / Tuxen, C. / Rokkedal, J. / Ibsen, H. / Devereux, R.B. | 1999
34A-c
Is the severity of hypertension related to different cardiac features in patients with left ventricular hypertrophy? The preserve study.
Palmieri, Vittorio / Bella, Jonathan N. / Dahlof, Bjorn / DeQuattro, Vincent / Sharpe, Norman / Fishman, Dawn / Devereux, Richard B. | 1999
35A
Impact of different partition values on prevalences of left ventricular hypertrophy and geometry: The life study
Wachtell, K. / Bella, J.N. / Liebson, P.R. / Gerdts, E. / Dahlöf, B. / Papademetriou, V. / Rokkedal, J. / Devereux, R.B. | 1999
36A
Altered adrenal sensitivity to angiotensin II. In low renin essential hypertension
Fisher, N.D.L. / Hurwitz, S. / Ferri, C. / Jeunmaitre, X. / Hollenberg, N.K. / Williams, G.H. | 1999
36A-a
Differential effects of valsartan (V) and lisinopril (L) on potassium [K+] homeostasis in hypertensive patients with nephropathy
Bakris, G.L. / Siomos, M. / Kasprowicz, S. / Bolton, W.K. / Hebert, L. / Catanzaro, D. / Janssen, I. | 1999
36A-b
Renal hemodynamic and hormonal responses to the angiotensin II antagonist, candesartan: The angiotensin II-renin short feedback loop.
Lansang, M.C. / Osei, S.Y. / Price, D.A. / Fisher, N.D.L. / Hollenberg, N.K. | 1999
37A
Academic detailing to promote hypertension (HTN) clinical practice guidelines.
Siegel, D. / Meier, J.L. / Lopez, J.R. | 1999
37A-a
Safety of sildenafil citrate in men with erectile dysfunction taking multiple antihypertensive agents.
Kloner, Robert / Brown, Morris / Sildenafil Study Group, | 1999
38A
Incidental renal artery stenosis detected during coronary angiography in hypertensive patients.
Textor, Stephen / Rihal, Charanjit / McKusick, Michael / Breen, Jerome / Robins, Catriona / Grill, Diane / Chabova, Vera / Schirger, Alexander | 1999
38A-a
Renal artery stent placement in patients seventy-five years of age or older
Bloch, M.J. / Trost, D.A. / Pickering, T.G. / Sos, T.A. / August, P. | 1999
38A-b
Reliability of echo-doppler velocimetric indices in reflecting renal hemodynamics in normal and stenotic kidneys
Alberti, C. / Nador, B. / Palatresi, S. / Airoldi, F. / Marana, I. / Bencini, C. / Lovaria, A. / Benti, R. / Longari, V. / Morganti, A. | 1999
38A-c
Urinary tetrahydro-aldosterone (thald) is yet the most reliable test for diagnosing primary aldosteronism (PA).
Abdelhamid, S. / Krumme, B. / Röckel, A. | 1999
39A
27 cases of primary aldosteronism: A clinical profile
Parasuraman, R. / Khan, A. / Makos, G. / Talpos, G. / Steigerwalt, S. | 1999
39A-a
Relationship of 24 HR BP levels with sleep disordered breathing (SDB) in a community sample
Wright, J.T. / Redline, S. / Russo, L. / Taylor, A.L. / Aylor, J. / Clark, C. / Graham, G. / Liao, G. / Tishler, P.V. | 1999
39A-b
The siesta in the elderly: A new risk factor for mortality?
Bursztyn, M. / Ginsberg, G. / Hammerman-Rozenberg, R. / Stessman, J. | 1999
40A
Post transplant hypertension: Role of nitric oxide-oxidative stress relationship
Calò, L. / Milani, M. / Davis, P.A. / Rigotti, P. / Marchini, F. / Cantaro, S. / Livi, U. / D'Angelo, A. / Antonello, A. | 1999
40A-a
L-arginine for testing endothelium-derived factors in essential hypertension
Cottone, S. / Vadalà, A. / Vella, M.C. / Riccobene, R. / Neri, A.L. / Zagarrigo, C. / Amato, F. / Cerasola, G. | 1999
40A-b
Nifedipine GITS, but not hydrochlorothiazide, improves flow-dependent vasodilation of brachial artery in essential hypertensive patients
Muiesan, L. / Salvetti, M. / Monteduro, C. / Rizzoni, D. / Zulli, R. / Brun, C. / Corbellini, C. / Agbati-Rosei, E. | 1999
40A-c
Influence of salt intake on endothelium-derived products in essential hypertension
Bragulat, E. / de la Sierra, A. / Antonio, M.T. / Gómez-Angelats, E. / Giner, V. / Sierra, C. / Aguilera, M.T. / Jiménez, W. / Coca, A. | 1999
41A
Influence of cardiovascular risk on the efficacy of antihypertensive treatment in the insight trial
Rosenthal, T. / Brown, M.J. / Castaigne, A. / de Leeuw, P.W. / Mancia, G. / Ruilope, L.M. | 1999
41A-a
Calcium-channel blockade improves cardiovascular prognosis in older diabetic patients with isolated systolic hypertension
Staessen, J. / Thijs, L. / Celis, H. / Fagard, R. / Syst-Eur Investigators, | 1999
41A-b
Subgroup analysis of the placebo-controlled chinese trial on isolated systolic hypertension in the elderly
Wang, J.G. / Staessen, J.A. / Liu, L.S. / Systolic Hypertension in China (Syst-China) Trial Investigators, | 1999
41A-c
Comparison of the effects of candesartan and losartan on ambulatory blood pressure in patients with essential ambulatory hypertension. A forced titration study.
Lacourcière, Y. / Asmar, R. / CHAMP study group, | 1999
42A
Influence of age and gender on preventing myocardial infarction by antihypertensive treatment and aspirin in the hot study.
Kjeldsen, S.E. / Kolloch, R. / Zanchetti, A. / Hansson, L. | 1999
42A-a
Placebo-associated blood pressure response and adverse effects.
Materson, B.J. / Preston, R.A. / Reda, D.J. / Williams, D. | 1999
42A-b
Effect of amlodipine on progression of carotid atherosclerosis in patients with documented heart disease
Byington, R. / Riley, W. / Booth, D. / Herrington, D. / Hunninghake, D. / Mallon, S. / Miller, M. / Ramanathan, K.B. / Werns, S. / Furberg, C.D. et al. | 1999
42A-c
BP control, LV mass and plasma norepinephrine: enalapril vs felodipine ER vs nifedipine gits
Leenen, F.H.H. / Toal, C.B. / Myers, M.G. | 1999
43A
A001: In vivo gene-transfer of calcitonin gene-related peptide (CGRP) reduces hypoxia-induced pulmonary hypertension in the mouse.
Champion, H.C. / Bivalacqua, T.J. / D'Souza, F.M. / Toyoda, Kazunori / Heistad, D.D. / Hyman, A.L. / Kadowitz, P.J. | 1999
43A-a
A002: Identification of molecular determinants of atrial natriuretic peptide receptor - a by deletion mutagenesis
Pandey, K.N. / Kumar, R. / Pandey, K. / Cartledge, W. / Li, M. | 1999
43A-b
A003: Polymorphisms of the {gamma} subunit of the epithelial sodium channel in essential hypertension. Relationship with salt-sensitivity
Poch, E. / Giner, V. / González, D. / de la Sierra, A. / Botey, A. / Coca, A. / Darnell, A. / Rivera, F. | 1999
43A-c
A004: ACE-I gene polymorphism and arterial hypertension: Lack of association in afro-venezuelan populations
Delgado, A.J. / Palacio, R. / Farías, R. / Mago, V. / Cermeño, J. / Fragachán, F. | 1999
44A
A005: Polymorphisms of the renin-angiotensin genes and the outcome of BP and microalbuminuria in essential hypertension: A prospective three years follow-up study
Redon, Josep / Chaves, Javier / Pascual, Jose M / Armengod, Maria E | 1999
44A-a
A006: Influence of polymorphic sites at the apolipoprotein (apo) A-I/C-III genelocus on lipid metabolism and atherosclerosis
v. Petzinger, A. / Dudek, M. / Lennarz, M. / Willinek, W.A. / Ludwig, M. / Stumpe, K.O. | 1999
44A-b
A007: Lack of association between ace gene polymorphism and left ventricular hypertrophy in essential hypertension
Gómez-Angelats, E. / Enjuto, M. / Oriola, J. / Paré, J.C. / Francino, A. / Poch, E. / Coca, A. / de la Sierra, A. | 1999
44A-c
A008: Polymorphisms in candidate genes for blood pressure regulation in young men with elevated screening blood pressure
Fossum, E. / Høieggen, A. / Berge, K.E. / Moan, A. / Rostrup, M. / Berg, K. / Kjeldsen, S.E. | 1999
45A
A009: D/I polymorphism of the ace gene and left ventricular hypertrophy
Kuznetsova, T. / Staessen, J.A. / Wang, J. / Vlietinck, R. / Fagard, R. | 1999
45A-a
A011: Occurrence of post-percutaneous transluminal coronary angioplasty restenosis: Role of cholesteryl ester transfer protein and paraoxonase
Zee, R.Y.L. / Irurita, M. / Macaya, C. / Pintor, E. / Fernandez-Cruz, A. / Lindpaintner, K. | 1999
45A-b
A010: SCAI polymorphism of the atrial natriuretic peptide gene in patients with coronary heart disease below 50 years of age with and without arterial hypertension
Sobiczewski, W. / Gruchala, M. / Targołski, R. / Dubaniewicz, W. / Romanowski, P. / Rynkiewicz, A. | 1999
45A-c
A012: Relationship between variants of AT1R gene with blood pressure levels in a spanish population. Results of an epidemiologic study
Carrión, L. / Martinez, E. / Sanchis, C. / Artigao, L.M. / Divison, J.A. / Massó, J. / Garcia, F. / Rodriguez, B. / Vidal, A. / Escribano, J. et al. | 1999
46A
A013: Associated evaluation of differents variants of Angiotensinogen gen and the relation with blood pressure levels. Results of an epidemiologic study
Puras, Angel / Martinez, Esperanza / Sanchis, Carlos / Carrión, Lucinio / Artigao, Miguel / Divison, Juan A. / Escribano, Julio / Fernandez, Juan A. | 1999
46A-a
A014: Association of angiotensin-converting enzyme polymorphism with lifestyle and family history of hypertension in stage I hypertensives
Winnicki, M. / Accurso, V. / Hoffmann, M. / Pawlowski, R. / De Venuto, G. / Dorigatti, F. / Berton, G. / Krupa-Wojciechowska, B. / Palatini, P. / HARVEST Study Group, | 1999
46A-b
A015: A Linkage Between Angiotensinogen Gene Polymorphism and Stage I Hypertension - the Harvest Study
Winnicki, M. / Accurso, V. / Hoffmann, M. / Pawlowski, R. / Mos, L. / Piccolo, D. / Krupa-Wojciechowska, B. / Palatini, P. / HARVEST Study Group, | 1999
47A
B001: Blood pressure and fluid electrolyte balance in D1A dopamine receptor-deficient mice.
Meunier, A.V. / O'Connell, D.P. | 1999
48A
C001: Isolation and characterization of human basic calponin gene promoter.
Nakamura, M. / Kitami, Y. / Maguchi, M. / Fukuoka, T. / Takata, Y. / Igase, M. / Okura, T. / Hiwada, K. | 1999
49A
D001: Long term effect of bilateral ovariectomy on endothelial function in spontaneously hypertensive rats. Role of nitric oxide.
Riveiro, A. / Mosquera, A. / Maeso, R. / Gude, F. / Calvo, C. | 1999
49A-a
D002: Irbesartan and enalapril ameliorate endothelial dysfunction in ovariectomized spontaneously hypertensive rats.
Riveiro, A. / Mosquera, A. / Maeso, R. / Gude, F. / Calvo, C. | 1999
49A-b
D003: Large-conductance calcium-activated K+ channels are involved in EDHF-mediated relaxations in the rat renal artery
Jiang, F. / Li, C.G. / Rand, M.J. / Pharmacology Research Group, | 1999
49A-c
D004: Increased vascular endothelial growth factor (VEGF) immunostaining in preeclampsia
Simmons, Lisa A. / Hennessy, Annemarie | 1999
50A
D005: Renovascular hypertension, aortic superoxide production and endothelial function: Effect of perindopril and indapamide
Harrison, D.G. / Schiavi, P. / Falgui, B.T. | 1999
50A-a
D006: Compensatory rise in vascular NO synthase (NOS) in young and severe NOS fall in old SHR: Prevention with losartan therapy
Wang, X.Q. / Shahinfar, S. / Kivlighn, S. / Vaziri, N.D. | 1999
50A-b
D007: Comparative study on zofenopril, lisinopril, enalapril and captopril effects on endothelin-1 and nitric oxide production
Desideri, G. / Bellini, C. / Bravi, M.C. / Giuliani, E. / Santucci, A. / Ferri, C. | 1999
50A-c
D008: Chronic estrogen replacement reduces vasoconstriction to angiotensin II and serotonin in female hypertensive transgenic (mREN2)27 rat aorta
Li, P. / Figueroa, J.P. / Ferrario, C.M. / Ganten, D. / Brosnihan, K.B. | 1999
51A
D009: Amelioration of hypertension (HTN) and nitric oxide synthase (NOS) expression with antioxidant therapy in spontaneously hypertensive rats (SHR).
Vaziri, N.D. / Ni, Z. | 1999
51A-a
D010: Effect of increased reactive oxygen species (ROS) on nitric oxide (NO) synthase (NOS) expression in cultured human endothelial cells.
Vaziri, N.D. / Wang, X.Q. | 1999
51A-b
D011: Divergent effects of felodipine on nitric oxide synthase (NOS) expression in different forms of hypertension in rats.
Ni, Z. / Ding, Y. / Vaziri, N.D. | 1999
51A-c
D012: Endothelin-1 (ET-1) in renin-dependent hypertension and related cardiovascular disease
Rossi, G.P. / Sacchetto, A. / Rizzoni, D. / Bova, S. / Porteri, E. / Cargnelli, G. / Mazzocchi, G. / Nussdorfer, G.G. / Pessina, A.C. | 1999
52A
D013: Interactions between endothelin-1 and the renin-angiotensin-aldosterone system (RAAS)
Rossi, G.P. / Sacchetto, A. / Cesari, M. / Nussdorfer, G.G. / Pessina, A.C. | 1999
52A-a
D014: Up-regulation of renal endothelial and inducible nitric oxide synthase in obstructive nephropathy.
Wang, Z-Q. / Siragy, H.M. / Chevalier, R.L. / Carey, R.M. | 1999
52A-b
D015: In vivo experiments of {gamma}HuEPO-derived hypertension.
Nakamura, S. / Nakayama, K. / Yang, C.L. / Aoki, T. | 1999
52A-c
D016: Effect of angiotensin II and noradrenaline on nitric oxide in the rabbit kidney.
Nakamura, S. / Nakayama, K. / Yang, C.L. / Aoki, T. / Kakumu, S. | 1999
53A
D017: A dual mechanism is involved in the protective effects of CoCl2 in DOCA/salt hypertension
Lofberg, E. / Akinsanmi, A. / McGiff, J.C / Oyekan, A.O. | 1999
53A-a
D018: Heme oxygenase / carbon monoxide system regulates blood pressure cooperatively with nitric oxide in hypertension.
Ushiyama, M. / Morita, T. / Katayama, S. | 1999
53A-b
D019: Restoration of nitric oxide function in the glomerular microcirculation of SHR by prolonged candesartan administration: role of O2-.
Welch, W.J. / Wilcox, C.S. | 1999
53A-c
D020: Altered cell signaling, reduced PKC, increased ecNOS mRNA and vascular hyporeactivity of Bartter's (BS) and Gitelman's (GS) syndrome.
Calò, L. / Milani, M. / Ceolotto, G. / Cantaro, S. / Sartori, M. / Favaro, S. / D'Angelo, A. / Semplicini, A. | 1999
54A
D021: VIPGC-NO preserves intrinsic function of VIP but acquires NO-like activities.
Jia, L. | 1999
54A-a
D022: Cytosolic proteins from human neutrophils bind to endothelial nitric oxide synthase mRNA: Regulation by tumor necrosis factor alpha.
Sánchez de Miguel, L. / De Frutos, T. / Farré, J. / Arriero, M.M. / Romero, J. / Rico, L.A. / Gómez, J. / González-Fernández, F. / Rodríguez-Feo, J.A. / Guerra, J.I. et al. | 1999
54A-b
D023: Endothelial dysfunction in a group of essential hypertensive patients related to salt-sensitivity
Bragulat, E. / de la Sierra, A. / Antonio, M.T. / Gómez-Angelats, E. / Giner, V. / Sierra, C. / Aguilera, M.T. / Jiménez, W. / Coca, A. | 1999
54A-c
D024: Relationship between endothelin and insulin-like growth factor-1 in essential hypertension.
Andronico, G. / Ferraro-Mortellaro, R. / Mangano, M.T. / Ferrara, L. / Lamanna, D. / Cerasola, G. | 1999
55A
D025: Preserved vascular responsiveness to acetylcholine in uncomplicated essential hypertensive patients
Dell'Omo, G. / Bandinelli, S. / Penno, G. / Pedrinelli, R. / Mariani, M. | 1999
55A-a
D026: Adolescence as a risk factor of pregnancy-induced hypertension (PIH). Relationship to endothelial function.
Barroso, S.G. / Duarte, A.V.B. / Morandi, V. / Silveira, C.S. / Alves, M.P.S. / Francischetti, E.A. / Fagundes, V.G.A. | 1999
55A-b
D027: Endothelial dysfunction marker allow the early diagnosis of pregnancy-induced-hypertension (PIH) in adolescents.
Duarte, A.V.B. / Barroso, S.G. / Morandi, V. / Alves, M.P.S. / Melo, V.C.L. / Francischetti, E.A. / Fagundes, V.G.A. | 1999
55A-c
D028: Vitamin E counteracts early VCAM-1 activation in hypercholesterolemic subjects.
Ferri, C. / Desideri, G. / Giuliani, E. / Bellini, C. / Santucci, A. | 1999
56A
D029: Simvastatin counteracts early endothelial activation in hypercholesterolemic hypertensives and normotensives. A fundamental tool for cardiovascular prevention?
Ferri, C. / Desideri, G. / Baldoncini, R. / Bellini, C. / Santucci, A. | 1999
56A-a
D030: L-arginine at a dose above 100 mg/kg is not suitable to examine endothelial function of renal vasculature.
Delles, C. / Jacobi, J. / Schlaich, M.P. / John, S. / Schmieder, R.E. | 1999
56A-b
D031: Synergistic bradycardia related to simultaneous infusion of L-arginine and acetylcholine.
Houghton, J.L. / Chander, R.C. / Kuhner, P.A. / Fein, S.A. / Carr, A.A. | 1999
56A-c
D032: Effect of uncomplicated hypertension on coronary vasoreactivity among similar African and white American subjects.
Houghton, J.L. / Fein, S.A. / Smith, V.E. | 1999
57A
D033: Effect of antihypertensive treatment on flow-dependent vasodilation of brachial artery in essential hypertensive patients
Muiesan, L. / Salvetti, M. / Monteduro, C. / Rizzoni, D. / Zulli, R. / Brun, C. / Corbellini, C. / Agabiti, Rosei E | 1999
57A-a
D034: Nifedipine improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
Virdis, A. / Taddei, S. / Buralli, S. / Ghiadoni, L. / Magagna, A. / Salvetti, A. | 1999
57A-b
D035: Effect of candesartan on endothelial function in the peripheral circulation of essential hypertensive patients.
Ghiadoni, L. / Virdis, A. / Taddei, S. / Magagna, A. / Vivaldi, S. / Notari, M. / Salvetti, A. | 1999
57A-c
D036: Vitamin C improves age-related endothelial dysfunction
Virdis, A. / Ghiadoni, L. / Salvetti, G. / Taddei, S. / Sudano, I. / Salvetti, A. | 1999
58A
E001: Is the central vasopressinergic system stimulated by angiotensin II?
Muders, F. / Elsner, D. / Bahner, U. / Jandeleit, K. / Riegger, G.A.J. / Palkovits, M. | 1999
58A-a
E002: Ouabain or an isomer is one of several inhibitors of Na-K-ATPase in human urine.
Kramer, H.J. / Bäcker, A. / Krampitz, G. / Pohlentz, G. | 1999
58A-b
E003: Effect of age on renal responses to COX-2 inhibitors, rofecoxib (VIOXX™, MK-0966), celecoxib and meloxicam, in conscious dogs.
Siegl, P.K.S. / Chan, C.C. / Bohn, D.L. / Evans, R.M. / Bunting, P.B. / Soper, K.A. / Patrick, D.H. | 1999
58A-c
E004: Receptor-mediated vasodilation effect of angiotensin 1-7(Ang 1-7) in the isolated rabbit afferent arteriole (Af-Art)
Ren, Y. / Garvin, J.L. / Carretero, O.A. | 1999
59A
E005: Correlates of vasodilatory effects of insulin in nondiabetic subjects.
Sung, B.H. / Shah, K. / Kidambi, S. / Wilson, M.F. | 1999
59A-a
E006: An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth
Tsuruda, T. / Kato, J. / Kitamura, K. / Imamura, T. / Koiwaya, Y. / Eto, T. | 1999
59A-b
E007: Elevated plasma levels and urinary excretion of ouabain like compound in cardiovascular deseases
Tóth, M. / Beck, M. / Horkay, F. / Szokodi, I. / Turbucz, P. / Szalay, KSz. / Leppäluoto, J. / deChâtel, R. | 1999
59A-c
E008: Humoral aspects of blood pressure rise in the morning at essential hypertension.
Svyshchenko, E. / Yarinkina, O. / Mkhytarian, L. / Mishchenko, L. / Kasimirko, E. / Rovenskaya, I. | 1999
60A
E009: Orthostatism modifies insulin-like growth factor 1 and insulin plasma levels in essential hypertension.
Andronico, G. / Ferrara, L. / Mangano, M.T. / Ferraro-Mortellaro, R. / Lamanna, D. / Cerasola, G. | 1999
60A-a
E010: Use of monoclonal antibodies for affinity chromatography of parathyroid hypertensive factor
Krylova, S. / Lauber, C. / Zhang, M. / Shan, J. / Benishin, C.G. | 1999
60A-b
E011: Plasma catecholamines and clonidine test in the differential diagnosis of essential hypertension and pheochromocytoma.
Mediavilla, J.D. / López de la Torre, M. / Piédrola, G. / Hidalgo, C. / León, L. / Aliaga, L. / Pinel, P. / Fernández, C. | 1999
60A-c
E012: Divergent effects of dihydropyridine and phenylalkylamine calcium antagonist on plasma norepinephrine before and after cold pressor test in mild to moderate hypertension.
Lefrandt, J.D. / Urbigkeit, A. / Sevre, K. / Castellano, M. / Hausberg, M. / Fallon, M. / Fluckiger, L. / Heitmann, J. / Rostrup, M. / Agabiti Rosei, E. et al. | 1999
61A
E013: Nitric oxide, cyclic guanosin monophosphate, endothelin-1, erythropoietin: relationship with ambulatory blood pressure monitoring in essential hypertension
Parrini, M. / Angelini, D. / Carlini, A. / Bigongiari, P. / Nardini, G. / Fiorini, I. / Antonelli, A. | 1999
62A
F001: Estrogen receptor-{alpha} in tumorigenesis: inhibition of cell growth, cell migration, vascular endothelial growth factor and integrin {alpha}v{beta}3 in ECV304 cells
Ali, S.H. / O'Donnell, A.L. / Balu, D. / Pohl, M.B. / Seyler, M.J. / Mousa, S. / Mohamed, S. / Dandona, P. | 1999
62A-a
F002: Ang II type 2 receptor activates JNK/SAPK-dependent signaling pathways.
Diep, Q. / Touyz, R.M. / Wu, X-H. / He, G. / Webb, A. / Schiffrin, E.L. | 1999
63A
G001: Abnormalities of the calcium pump in essential hypertension
Sobrino, J. / de la Sierra, A. / Ribera, L. / Adrian, M.J. / Aguilera, M.T. / Coca, A. | 1999
63A-a
G002: Urinary aldosterone and sodium reabsorption in the distal nephron correlate with the activity of amiloride-sensitive sodium channels.
Wang, Q. / Burnier, M. / Maillard, M. / Parisod, Y. / Brunner, H.R. / Nussberger, J. | 1999
63A-b
G003: Altered cAMP-response in T594M variant of amiloride sensitive sodium channel in human transformed lymphocytes
Cui, Y. / Su, Y.R. / Layne, M. / Carter, V. / Menon, A.G. / Reif, M.C. / Pun, R.Y.K. | 1999
63A-c
G004: Distinction between bumetanide-sites at rat Na-K-Cl cotransporters BSC1 and BSC2
Pirot, D. / Alvarez-Guerra, M. / Nazaret, C. / Hannaert, P. / Garay, R.P. | 1999
64A
G005: Identification of the chloride transport protein responsible for the increased renal NaCl reabsorption in Dahl salt-sensitive rats
Alvarez-Guerra, M. / Garay, R.P. | 1999
64A-a
G008: Cellular calcium/magnesium antagonism in primary hypertension
Kisters, K. / Barenbrock, M. / Hausberg, M. / Westermann, G. / Kosch, M. / Rahn, K.H. | 1999
64A-b
G006: Effect of estrogen replacement therapy on blood pressure and intracellular electrolytes
Cardona, M.Q. / de la Sierra, A. / Aguilera, M.T. / Coca, A. / Urbano-Márquez, A. | 1999
64A-c
G007: The significance of a decreased erythrocyte potassium in the management of severe essential hypertension.
Delgado-Almeida, A. / Delgado-Leon, C. / Delgado, M.C. | 1999
65A
G009: Early signs of insulin resistance in normotensive offspring of hypertensives with low RBC K content
Delgado, M.C. / Delgado-Leon, C. / Delgado-Almeida, A. | 1999
65A-a
G010: Red blood cell Na+/K+ atpase and Na+/K+/2CL- countertransport activity in patients with syndrome X.
Gaspardone, A. / Ferri, C. / Crea, F. / Tomai, F. / Versaci, F. / Desideri, G. / Bellini, C. / Santucci, A. / Gioffrè, P.A. | 1999
65A-b
G011: Insulin and membrane function of erythrocytes in essential hypertension -an electron paramagnetic resonance investigation-
Kinoshita, Y. / Tsuda, K. / Nishio, I. / Masuyama, Y. | 1999
66A
H001: Ambulatory blood pressure and procolagen amino-terminal polypeptide (P-III-P)
Moreira, C.S. / Serejo, F. / Ramalhinho, V. / Gato-Varela, M. / Alcântara, P. / Braz-Nogueira, J. | 1999
66A-a
H002: Presence of chlamydia pneumoniae in cultured human smooth muscle cells from arteries with and without atherosclerotic lesions
Korakianitou, I.K. / Sudmann, M. / Lennarz, M. / Lewen, V. / Böhm, C. / Schnabel, D. / Stumpe, K.O. | 1999
66A-b
H003: Highly increased ICAM-1 levels in essential hypertension: correlation to proinflammatory cytokines levels.
Paletas, K. / Boura, P. / Magoula, I. / Alexiadis, S. / Tsapas, A. | 1999
66A-c
H004: Essential hypertension, unstable angina and the immune link in homeostasis.
Tashchuk, V.K. / Melnitsky, I.V. / Dubrovska, G.V. / Polyanska, O.S. / Ilashchuk, I.I. | 1999
67A
I001: High glucose and hyperinsulinemia inhibit MKP-1 expression in aortic smooth muscle cells by blocking the induction of iNOS
Begum, N. / Ragolia, L. / Duddy, N. / Koshy, B. | 1999
67A-a
I002: Hemodynamic effects of an intravenous glucose tolerance test in normotensives subjects
Rhéaume, C. / Waib, P. / Marceau, M. / Lacourcière, Y. / Cléroux, J. | 1999
67A-b
I003: Comparison of regional hemodynamic responses after exhausting exercise in normotensive and hypertensive subjects.
Marceau, M. / Rhéaume, C. / Lacourcière, Y. / Cléroux, J. | 1999
67A-c
I004: {alpha}-soomth muscle actin (SMA) and collagen type III (COLIII) in myocardium (MC) of diabetic rats untreated with insulin.
Toblli, J.E. / Stella, I. / Nyberg, C. / Ferder, L. / Inserra, F. | 1999
68A
I005: Defective dopamine receptor G-protein function contributes to reduced dopamine-mediated inhibition of Na,K-ATPase in proximal tubules of obese zucker rats
Hussain, Tahir / Beheray, Sucheta A. / Lokhandwala, Mustafa F. | 1999
68A-a
I007: Hyperinsulinaemia and reninaldosterone system in morbid obesity.
Andronico, G. / Ferraro-Mortellaro, R. / Ferrara, L. / Mangano, M.T. / Mulé, G. / Piazza, G. / Cerasola, G. | 1999
68A-b
I006: Dissociation between diabetic retino and nephropathy in experimental type II diabetes. Effects of irbesartan.
Garcia-Robles, R. / Villalba, F. / Gonzalez, O. / Villa, E. / Rabano, A. / Rocamora, A. / Moreno, B. / Calvo, S. / Sancho, J.M. / Ruilope, L.M. | 1999
68A-c
I008: Hypertension and visceral fat accumulation: a community-based study in Oporto, Portugal.
von Hafe, P. / Pérez, A.M. / Froufe, P. / Ramos, E. / Lopes, C. / Maciel, M.J. / Barros, H. | 1999
69A
I009: Dual effects of epinephrine on blood glucose during hyperinsulinemia in borderline hypertensive young men
Høieggen, A. / Fossum, E. / Moan, A. / Eide, I. / Kjeldsen, S.E. | 1999
69A-a
I010: Insulin resistance and ACE-I gene polymorphism in Afro-venezuelan hypertensive patients.
Delgado León, Antonio J. / Farías, Rosa / Fragachán, Francisco | 1999
69A-b
I011: Insulin resistance in hypertensive Afro-venezuelan subjects.
Farías, R. / Delgado, A.J. / Palacio, R. / Mago, V. / Cermeño, J. / Bredy, R. / Fragachán, F. | 1999
69A-c
I012: Interrelation between blood pressure and glucose and lipid parameters in men with arterial hypertension and diabetes type-2 in the post-myocardial infarction period.
Matveeva, S.A. | 1999
70A
I013: Hypotensive effect of lacidipine vs lisinopril in hypertensive NIDDM patients.
Kurashvili, R.B. / Chumburidze, V.B. / Kikalishvili, T.T. / Asatiani, N.G. | 1999
70A-a
I014: Captopril effectivity in patients with hypertension and diabetes
Khelashvili, M.G. / Kurashvili, R.B. / Chumburidze, V.B. | 1999
70A-b
I015: Stress-induced pulse pressure in young adult mild hypertensives with insulin resistance
Nazzaro, P. / Manzari, M. / Merlo, M. / Triggiani, R. / Scarano, A.M. / Ciancio, L. / Vapore, G. / Pirrelli, A. | 1999
70A-c
I016: Effects of Celipropol, Irbesartan and Lisinopril on insulin sensitivity in non diabetic hypertensive patients.
Mugellini, A. / Poletti, L. / Zoppi, A. / Lazzari, P. / Preti, P. / Corradi, L. / Fogari, R. | 1999
71A
I017: Blood pressure increase in hyperglycemia
Cinar, Y. / Şenyol, A.M. / Başar, M. | 1999
71A-a
I018: Dietetic profile and the insulin resistance syndrome in overweight hypertensive Brazilian patients
Barroso, S.G. / Fagundes, VGA. / Rodrigues, MLG. / Sanjuliani, A.F. / Silveira, C.S. / Tronco, ALS. / Neto, J.F. / Francischetti, E.A. | 1999
71A-b
I019: Vitamin C improves acetylcholine-stimulated vasodilation in obese subjects
Perticone, F. / Ceravolo, R. / Cloro, C. / Candigliota, M. / Ventura, G. / Mattioli, P.L. | 1999
71A-c
I020: Syndrome W: a new model of hyperinsulinemia, hypertension and other CAD risk factors in healthy midlife women with normal glucose tolerance
Mogul, H.R. / Weinstein, B. / Mogul, D. | 1999
72A
I021: Physiologic doses of insulin decrease central systolic blood pressure without changing peripheral vascular resistance in normal subjects
Vehkavaara, S. / Westerbacka, J. / Yki-Järvinen, H. | 1999
72A-a
I022: Dynamics of the angiotensin-converting enzyme activity and insulin resistance in patients with metabolic syndrome treated with moxonidin.
Britov, A.N. / Aparina, T.V. / Gomazkov, O.A. / Nebieridze, D.V. / Metelskaya, V.A. / Mamedov, M.N. | 1999
72A-b
I023: Relationships between chronic hyperinsulinemia, heart rate variability.
Galinier, M. / Fourcade, J. / Boveda, S. / Solera, S. / Solera, M.L. / Massabuau, P. / Cabrol, P. / Fauvel, J.M. / Valdiguie, P. / Bounhoure, J.P. | 1999
72A-c
I024: Effects of weight loss on multiple cardiovascular disease risk factor reduction: One-year of treatment with Orlistat.
Lucas, C. / Hauptman, J. / Dallas, J. / Nichols, G. / Segal, K.R. | 1999
73A
I025: Insulin resistance and hypertension in lean postmenopausal women.
Feldstein, C.A. / Renauld, A. / Cauterucci, S. / Akopian, M. / Calcagno, M. / Garrido, D. | 1999
73A-a
I027: Hypertension and obesity. Influence of life style modifications
Santos, R.M. / Macedo, M.E. / Monteiro, A. / Freitas, J. / Marujo, C. / de Freitas, A.Falcão | 1999
73A-b
I026: Handgrip test as a tool to assess modifications in autonomic control of heart rate at essential hypertension
Voita, D. / Mackevics, V. / Vitols, A. | 1999
73A-c
I028: Obesity, high blood pressure and autonomic nervous system.
Santos, R.M. / Freitas, J. / Carvalho, M.J. / Macedo, M.E. / de Freitas, A Falcão | 1999
74A
I029: Duration of diabetes affects cardiac function in asymptomatic, normotensive type II diabetes.
Shah, K. / Vallabhan, T. / Kidambi, S. / Sung, B.H. | 1999
74A-a
I030: Prevalence of impaired diurnal variation in asymptomatic, normotensive type II diabetics.
Kidambi, S. / Sung, B.H. / Shah, K. / Vallabhan, T. / Wilson, M.F. | 1999
74A-b
I031: Effects of supplemented Taohe Chengqi Decoction in treating insulin resistance in rats with non-insulin dependent diabetes mellitus
Ze-en, Li. / An-zhong, Lin / Zhang-zhi, Zhu / Wen-jiu, Chai | 1999
74A-c
I032: Profile of insulin secretion over 24 hours period in hypertensive and normotensive obese men and blood pressure.
González-Albarrán, O. / Calvo, S. / Villalba-Díaz, F. / Hurtado, A. / Sancho, J. / García-Robles, R. | 1999
75A
I033: Results of an outcome survey in 2414 unselected patients with diabetes type 2: Effects of cilazapril on renal and cardiovascular function
Delles, C. / Veelken, R. / Schmieder, R.E. | 1999
75A-a
I034: Prevalence of hypertension and occurrence of new cases of hypertension in diabetic subjects: Correlation with their antidiabetic treatment
Bourmendil, E.F. / Mugnier, C. | 1999
75A-b
I035: The association between left ventricular hypertrophy, hyperleptinemia and the insulin resistance syndrome.
Pladevall, M. / Guyer, H.M. / Yañez, A.M. / Sadurní, J. / Falces, C. / Planas, A. | 1999
76A
J001: BP dependent and independent effects of salt on the pathogenesis of hypertension induced renal damage (HIRD) in the stroke prone SHR (SHRsp).
Griffin, K. / Picken, M. / Churchill, P. / Churchill, M. / Webb, C. / Bidani, A. | 1999
76A-a
J002: Aldosterone reverses the protective effects of adrenalectomy against end-organ damage in stroke-prone spontaneously hypertensive rats
Rocha, R. / Chander, P.N. / Zuckerman, A. / Mullen, D. / Bhasin, K. / Stier, C.T. | 1999
76A-b
J003: Oxidative stress in hypertensive with left ventricular hypertrophy= preliminary report.
Broche, F.J. / Cespedes, E. / Garcia, J. / Leal, E. / Sanchez, R. | 1999
76A-c
J004: Altered resistance artery wall composition in SHR: Normalization by irbesartan.
Intengan, H.D. / Li, J.S. / Schiffrin, E.L. | 1999
77A
J005: Silent myocardial ischemia and the relationship with cardiovascular endorgan damage in newly found hypertensives.
Terpstra, W.F. / May, J.F. / Smith, A.J. / de Graeff, P.A. / Crijns, H.J.G.M. | 1999
77A-a
J006: Abnormal baseline endothelial dysfunction and thrombogenesis are related to prognosis in hypertension
Edmunds, E. / Blann, A.D. / Beevers, D.G. / Lip, GYH. | 1999
77A-b
J007: Relation between casual blood pressure and target organ damage in untreated hypertensive course
Takatsugi, K. / Okuda, Y. / Konishi, S. / Mukai, M. / Matsuzaki, K. / Murakami, E. | 1999
77A-c
J008: Protective effect of Benazepril on kidney in patients with essential hypertension.
Shude, Tang / Hang, Qi Wen | 1999
78A
J009: Comparison of pulse wave velocity among normotensives, white coat and sustained hypertensives with and without diabetes or dislipidemia.
Ribeiro, L. / Santos, A. / Gama, G. / Asmar, R. / Polónia, J. | 1999
78A-a
J010: Humoral and hemodynamic correlates of hepatocyte growth factor in end stage renal disease
Malatino, L.S. / Tripepi, G. / Benedetto, F.A. / Mallamaci, F. / Marino, C. / Garozzo, M. / Di Vincenzo, F. / Arena, C. / Cataliotti, A. / Bellanuova, I. et al. | 1999
78A-b
J011: Exercise blood pressure as a determinant of left ventricular mass and geometry in patients with hypertension.
Franceschini, L. / Gallo, A. / Zamboni, A. / Albani, A. / Tomei, R. / Rossi, L. / Zanolla, L. / Zardini, P. | 1999
78A-c
J012: Transvascular albumin leakage and urinary albumin excretion in uncomplicated essential hypertensive subjects
Pedrinelli, R. / Dell'Omo, G. / Penno, G. / Bandinelli, S. / Giorgi, D. / Di Bello, V. / Mariani, M. | 1999
79A
J013: Microalbuminuria and concentric hypertrophy in essential hypertension
Pedrinelli, R. / Di Bello, V. / Dell'Omo, G. / Giorgi, D. / Bandinelli, S. / Penno, G. / Mariani, M. | 1999
79A-a
J014: Is there a correlation between left ventricular hypertrophy, hypertension and age?
Ciocon, J.O. / Capili-Rosenkranz, Erlinda | 1999
79A-b
J015: Non-dipper hypertensives have increased microalbuminuria irrespectively of diabetes mellitus
Vyssoulis, G.P. / Triantafillou, A.J. / Karpanou, E.A. / Toutouza, M.G. / Tselika, C.S. / Toutouzas, P.K. | 1999
79A-c
J016: Atorvastatin and Vitamin C on endothelial function of hypercholesterolemic patients
Perticone, F. / Ceravolo, R. / Maio, R. / Iacopino, S. / Ventura, G. / Giancotti, F. / Mattioli, P.L. | 1999
80A
J017: Hypertensive left ventricular hypertrophy but not ace-gene polymorphism affects adverse outcomes.
Perticone, F. / Schillaci, G. / Verdecchia, P. / Cuccurullo, O. / Cosco, C. / Maio, R. / Trapasso, M. / Mattioli, P.L. | 1999
80A-a
J018: Carotid thickening in hypertensives and white coat hypertensives.
Alcântara, P. / Moreira, C. / Oliveira, V. / Braz-Nogueira, J. / Ravara, L. | 1999
80A-b
J019: Endothelial dysfunction is an independent predictor of left ventricular hypertrophy in untreated hypertension
Marchesi, S. / Schillaci, G. / Vaudo, G. / Lupattelli, G. / Verdecchia, P. / Mannarino, E. | 1999
80A-c
J020: Relationship between heart rate during ambulatory blood pressure monitoring and urinary albumin excretion in mild hypertension.
Armario, P. / Hernández del Rey, R / Torres, G. / Martin-Baranera, M. / Almendros, M.C. / Ruigómez, J. / Pardell, H. | 1999
81A
J021: High prevalence of retinal vascular changes in early phases of essential hypertension
Lonati, L. / Cuspidi, C. / Sampieri, L. / Zaro, T. / Michev, I. / Macca, G. / Valagussa, L. / Leonetti, G. / Zanchetti, A. | 1999
81A-a
J022: Defining the relationship between BP and target organ damage: The hot target-organ substudy
Haley, W.E. / Harris, T.M. / Tucker, C.T. / Zachariah, P.K. | 1999
81A-b
J023: Early changes in left ventricular function and geometry in patients with mild mitral or aortic regurgitation. the life study
Papademetriou, V. / Narayan, P. / Dahlof, B. / Wachtell, K. / Gerdts, E. / Nieminne, M. / Nielsen, J. / Devereux, R.B. | 1999
81A-c
J024: Microalbuminuria is an integrated marker of increased cardiovascular risk and target organ damage in essential hypertension
Pontremoli, R. / Ravera, M. / Viazzi, F. / Berruti, V. / Leoncini, G. / Nicolella, C. / Bezante, G.P. / Del Sette, M. / Lotti, R. / Sacchi, G. et al. | 1999
82A
J025: Prediction of left ventricular mass (LVM) in the elderly by casual measurement and ambulatory blood pressure monitoring (ABPM)
Ruiz-Nodar, J.M. / Arco-Galán, C. / Aguilar, R. / Martinez-Elbal, L. / Méndez-García, J. / Pizzaro, A. / Fernández, M. / Gabriel, R. / Suárez, C. | 1999
82A-a
J026: Microalbuminuria, pulse pressure, left ventricular hypertrophy and myocardial ultrasonic textural parameters (videodensitometry) in arterial hypertension
Di Bello, V. / Pedrinelli, R. / Giorgi, D. / Bertini, A. / Talini, E. / Dell'Omo, G. / Caputo, M.T. / Cioppi, A. / Giusti, C. | 1999
82A-b
J027: Do patients with de novo hypertension differ from those with previously known hypertension when malignant phase hypertension occurs?
Lip, G.Y.H. / Beevers, M. / Beevers, D.G. | 1999
82A-c
J028: Malignant hypertension: the 10-year experience of a hypertension unit in athens, greece
Efstratopoulos, A.D. / Voyaki, S.M. / Lydakis, H. / Meikopoulos, M. / Kolettas, C.h. / Karabatsaki, H. / Eliadi, H. | 1999
83A
J029: Night-time blood pressure is more important than daytime blood pressure for left ventricular mass in hypertension
Missault, L.H. / De Buyzere, M.L. / Duprez, D.A. / Clement, D.L. | 1999
83A-a
J030: Microalbuminuria in never-treated hypertensives : relations with left ventricular characteristics, insulin sensitivity and genetic predisposition to hypertension.
Grandi, A.M. / Zanzi, P. / Santillo, R. / Gaudio, G. / Broggi, R. / Imperiale, D. / Colombo, S. / Guasti, L. / Bertolini, A. / Venco, A. | 1999
83A-b
J031: Regression of left ventricular hypertrophy and heart rate variability in hypertensive patients
Tasić, I.S. / Lović, B.K. / Ilić, S. / Dordević, D. / Deljanin-Ilić, M. / Nikolić, A. / Milovanović, I. / Petrović, D. / Lović, D. / MiladinovićTasić, N. | 1999
83A-c
J032: Relationship between left ventricular mass, blood pressure and microalbuminuria in a secondary referral hypertension clinic
Gatzka, C.D. / Reid, C.M. / Lux, A. / Dart, A.M. / Jennings, G.L. | 1999
84A
J033: Correlates of left ventricular mass in a population sample aged 35 to 64 years
Jula, A. / Karanko, H. / Aaltonen, T. | 1999
84A-a
J034: Screening of elderly patients for abdominal aortic aneurysms during echocardiography
Grandinetti, O. / Matrangolo, E. / Ortale, C. / Chiappetta, P. / Lidonnici, D. / De Marco, A. / Mirabelli, F. / Benatti, G. / Italian Cardiogeriatric Group (GIC-A.N.C.E.), | 1999
85A
K001: The barlovento study: prevalence of arterial hypertension in black communities of venezuela.
Farías, R. / Delgado, A.J. / Guggisberg, W. / Alvarez, R. / Chuki, E. / Fragachán, F. | 1999
85A-a
K002: Anthropometric evaluation and its correlation with blood pressure: A study in afro-venezuelan population
Delgado, AJ. / Farías, R. / Guggisberg, W. / Alvarez, R. / Chuki, E. / Fragachán, F. | 1999
85A-b
K003: Hypertensive patients evaluated in the arterial hypertension unit in 1997: Clinical-epidemiological features
Guggisberg, W. / Farías, R. / Delgado, A.J. / Alvarez, R. / Chuki, E. / Fragachán, F. | 1999
85A-c
K004: Dehydroepiandrosterone serum levels and arterial hypertension: Study in afro-venezuela men
Fragachán, F. / Delgado, A.J. / Palacio, R. / Farías, R. / Mago, V. / Cermeño, J. | 1999
86A
K005: Is the prevalence of hyperuricemia in essential hypertension decreasing?
Campo, C. / Segura, J. / Alcázar, J.M. / Ruilope, L.M. | 1999
86A-a
K006: Risk factor clustering in hypertension; significance of NCEP-II, EAS and 1997 diabetes expert committee reports for the implementation of JNC-VI guidelines
Stern, Naftali / Grosskop, Itamar / Shapira, Itzchak / Kisch, Eldad / Isaacov, A. / Limor, Rona / Baz, Merav / Leshem, Yehoshua / Flatau, Edith / Miller, Agnes et al. | 1999
86A-b
K007: The association of calcium channel blocker and cancer: Does the hypothesis withstand the scrutiny of the epidemiologic principles of causation?
Roht, L.H. / Rubenstein, E.B. / Mason, R.P. / Beach, C.L. / Sun, C.C. / Martin, C.G. / Manzullo, E. | 1999
86A-c
K008: Hypertension in children: Care in diagnosis
Machado, C.E. / Souza, R. / Peccini, K. / Boscoli, A. / Baptista, L. / Barbieri, E. / Misael, A.M. | 1999
87A
K009: Variability of office blood pressure during one-year and cardiovascular accidents in the elderly treated hypertensives
Hata, Y. / Kimura, Y. / Muratani, H. / Fukiyama, K. / Kawano, Y. / Ozawa, T. / Yokouchi, M. / Imai, Y. / Ashida, T. / Fujii, J. et al. | 1999
87A-a
K010: Pretreatment blood pressure, as a risk factor for 21-year mortality, decreases with increasing age.
Perry, H.M. / Miller, J.P. / Baty, J.D. / Carmody, S.E. / VA HSTP Group, | 1999
87A-b
K011: Prevalence of left ventricular hypertrophy in elderly population
Ruiz-Nodar, J.M. / Aguilar, R. / Martinez-Elbal, L. / Arco-Galán, C. / Méndez-García, J. / Fernández, M. / Pizarro, A. / Gabriel, R. / Suarez, C. | 1999
87A-c
K012: Personal digital assistant (hand-held) computers technology for cardiovascular risk factor management
Phillips, R.A. / Kannry, J. / Siu, A. / Hwang, C. | 1999
88A
K013: Improved outpatient hypertension control with disease management guidelines.
Townsend, R.R. / Shulkin, D.J. / Bernard, D. | 1999
88A-a
K014: Four year follow-up of treated patients with nocturnal hypertension controlled by ambulatory blood pressure monitoring
Carmona, J. / Amado, P. / Vasconcelos, N. / Almeida, L. / Santos, I. / Nazaré, J. | 1999
88A-b
K015: Long-term prognosis of hypertension in pregnancy
Marín, R. / Gorostidi, M. / Portal, C. / Sánchez, M. / Sánchez, E. / Fernández, F. / Álvarez, J. | 1999
88A-c
K016: Raised serum uric acid levels are associated with increased risk for stroke and heart attack
Ward, H. / Pan, D. | 1999
89A
K017: Hypertension in pregnancy: Changes during a 24-year observational study
Marín, R. / Gorostidi, M. / Portal, C. / Sánchez, M. / Fernández, F. / Álvarez, J. | 1999
89A-a
K018: Sex-specific associations of hypertension with lipid levels in a representative sample
Ferrières, J. / Raetz, S. / Amouyel, P. / Arveiler, D. / Ruidavets, J.B. / Cottel, D. / Lamamy, N. / Bingham, A. / Ducimetière, P. | 1999
89A-b
K019: Predictive role of gender on blood pressure control
Pannarale, G. / Acconcia, M.C. / Gaudio, C. / Ferri, F. / Pannitteri, G. / Schiariti, M. | 1999
89A-c
K020: Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population
Ferrières, J. / Elias, A. / Ruidavets, J.B. / Cantet, C. / Bongard, V. / Boccalon, H. | 1999
90A
K021: Atlas project: a global pharmacoeconomical evaluation of antihypertensive treatment
Degli Esposti, E. / Sturani, A. / Macini, P.L. / Buda, S. / Cocchi, R. / Di Nardo, A.M. / Fabbri, A. / Lucatello, A. / Pasi, A. | 1999
90A-a
K022: Association of sympathetic activity (resting heart rate) with serum cholesterol but not with blood pressure in young normotensive subjects
Weisser, B. / Mengden, T. / Grohé, C. / Lottermoser, K. / Vetter, H. | 1999
90A-b
K023: Arterial hypertension in children: The procorlujan 97 program. Preliminary results
Fernandez Contreras, R. / Gomez Llambi, H. / Villa, D. / Puglia, D. | 1999
90A-c
K024: Relationship between birth weight and adolescent and adult blood pressure and baroreflex sensitivity: A 14 years follow up study
Rabbia, F. / Veglio, F. / Cat Genova, G. / Martini, G. / Riva, P. / Grosso, T. / Morra di Cella, S. / Milan, A. / Chiandussi, L. | 1999
91A
K025: A working day evaluation of the dyslipidemia in a Spanish population ("JADE" study): A sub-analysis of the hypertensive patients.
Martínez-González, J. / Gómez-Gerique, J.A. / Fernández-Arias, I. / Espejo-Martínez, J. | 1999
91A-a
K026: Obesity influences the urinary sodium excretion in children and adolescents
Lurbe, Empar / Cremades, Beatriz / Torró, Isabel / Rodriguez, Concepción / Tacons, Jose / Alvarez, Vicente / Redon, Josep | 1999
91A-b
K040: The role of 24-hour blood pressure monitoring in predicting the development of sustained hypertension after 6 months of follow-up. Hospitalet study.
Hernández-del Rey, R. / Armario, P. / Martin-Baranera, M. / Sanchez, P. / Almendros, M.C. / Coca, A. / Pardell, H. | 1999
91A-c
K028: Gender differentials in blood pressure and cardiovascular disease in the Barbados eye study.
Hennis, A. / Wu, S-Y. / Nemesure, B. / Li, X. / Leske, M.C. / Barbados Eye Study Group, | 1999
92A
K029: Population blood pressure control in patients with diabetes and congestive heart failure.
L'Italien, G.J. / Lapuerta, P. | 1999
92A-a
K030: Awareness, treatment, and control of systolic blood pressure in the United States.
Lapuerta, P. / L'Italien, G.J. | 1999
92A-b
K031: High blood pressure levels prevalence in children from Braganca Paulista -- SP -- Brasil
Machado, C.E. / Souza, R. / Peccini, K. / Boscoli, A. / Baptista, L. / Sanoda, R. / Misael, A. | 1999
92A-c
K032: Is high blood pressure a predisposing factor to renal lithiasis?
Machado, C.E. / Souza, R. / Misael, A.M. / Sanoda, R.Y. / Salvatti, L.G. / Campos, C.P. / Santi, D.N. / Marzochi, L.M. / Domienikan, M.S. / Benedetti, M.E. | 1999
93A
K033: Treatment and control of hypertension in adult diabetics in Northwest Indiana.
Elliott, W.J. / Toth, S.J. / Stemer, A. / Cadwalader, J. / Inland/United Steelworkers of America Healthcare Network, | 1999
93A-a
K034: Clinical sequelae after becoming lost-to-follow-up in a tertiary hypertension clinic.
Elliott, W.J. | 1999
93A-b
K035: Pulse pressure and cardiovascular mortality in normotensive borderline and hypertensive subjects. Results of a Brisighella Heart Study.
Dormi, A. / Borghi, C. / Galletti, C. / Rimondi, S. / Gaddi, A. | 1999
93A-c
K036: Time -course and risk profile of isolated systolic hypertension in the young
Vriz, O. / Bettio, M. / Frigo, G. / Dorigatti, F. / Palatini, P. / HARVEST Study Group, | 1999
94A
K037: Clustering of cardiovascular risk factors in young adults: The Odense Schoolchild Study
Lambrechtsen, J. / Rasmussen, F. / Jacobsen, I.A. / Hansen, H.S. | 1999
94A-a
K038: Birth weight and cardiovascular risk factors in Japanese young adults.
Minami, J. / Suzuki, T. / Ohrui, M. / Ishimitsu, T. / Hisauchi, T. / Matsuoka, H. | 1999
94A-b
K039: Prevalence, awareness, treatment and control of hypertension in Greece: The Didima study.
Stergiou, G.S. / Thomopoulou, G.C. / Skeva, I.I. / Mountokalakis, T.D. | 1999
94A-c
K040: Role of age on the effects of blood pressure, heart rate, and cholesterol on cardiovascular mortality
Benetos, A. / Thomas, F. / Guize, L. | 1999
95A
K041: Prevalence, awareness, treatment and control of hypertension in people over eighty in Spanish population.
Saez, T. / Suarez, C. / del Arco, C. / Mendez, J. / Pizarro, A. / Fernandez-Escribano, M. / Gabriel, R. / Vega, S. / EPICARDIAN Study group, | 1999
95A-a
K042: Tracking of cardiovascular risk factors from childhood to adulthood: The Odense Schoolchild Study
Lambrechtsen, J. / Rasmussen, F. / Jacobsen, I.A. / Hansen, H.S. | 1999
95A-b
K043: Changes in blood pressure and adiposity throughout adulthood and their relationship to physical activity in overweight and never-overweight groups: The Fels Longitudinal Study.
Siervogel, R.M. / Wisemandle, W.A. / Towne, B. / Maynard, L.M. / Guo, S.S. / Chumlea, W.C. | 1999
95A-c
K044: Decreased prevalence and improved control of hypertension in the Czech population
Cífková, R. / Škodová, Z. / Hejl, Z. / Adámková, V. / Novozámská, E. / Pit'ha, J. / Jozífová, M. / Šraierová, D. / Hauserová, G. / Dušková, A. et al. | 1999
96A
K045: Pharmacologic treatment of hypertension among the South Carolina Medicaid population.
Lackland, D. / Egan, B. / Durkin, M. / Gunter, N. / Williams, B. | 1999
96A-a
K046: Non-insulin-dependent diabetes mellitus as an aggravating factor in hypertensive patients with carotid atherosclerosis
Grandinetti, O. / Mazzei, B. / Pranno, L. / Zottola, C. / Muti, V. | 1999
96A-b
K047: Yield of renal arteriography (RA) in the evaluation of pediatric hypertension.
Shahdadpuri, J. / Frank, R. / Gauthier, B.G. / Siegel, D.N. / Trachtman, H. | 1999
97A
A001: Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes.
Lijnen, P. / Fagard, R. / Petrov, V. | 1999
97A-a
A002: Effects of different doses of moexipril and HCTZ alone or in combination on postmenopausal osteoporosis and hypertension in ovariectomized spontaneously hypertensive rats
Stimpel, M. / Yao, W. / Lu, J. / Setterberg, R.B. / Zhou, H. / Jee, WSS. / Ma, Y.F. | 1999
97A-b
A003: Renal tubular Ang I, Ang II, renin, and prorenin prosequence immunostaining in Dahl S and R rats: Lack of change with salt intake
Campbell, W.G. / Catanzaro, D.F. / Laragh, J.H. / Sealey, J.E. | 1999
97A-c
A004: Age and baseline blood pressure influence pressor effects of angiotensin II.
Sung, B.H. / Shah, K. / Kidambi, S. / Wilson, M.F. | 1999
98A
A005: Effects of angiotensin I and II and captopril on in vitro erythropoiesis.
Collart, F. / Corazza, F. / Hermans, C. / Wens, R. / Fondu, P. / Dratwa, M. | 1999
98A-a
A006: Mechanical strain increases collagen I mRNA expression in cultured human vascular smooth muscle cells via an angiotensin II-dependent pathway
Stanley, A.G. / Williams, B. | 1999
98A-b
A007: Effects of cholesterol on interaction of angiotensin II and insulin on dorsal hand vein.
Varga, C. / Sung, B.H. / Kidambi, S. / Shah, K. / Vallabhan, T. / Wilson, M.F. | 1999
98A-c
A008: Inhibitory effect of PD098059 on angiotensin II induced-mitogen activated protein kinase activation.
Zhu, S.J. / Chen, G.H. / Zhu, Z.M. / Hu, H.X. / Luo, X.D. | 1999
99A
A009: Baseline blood pressure predicts constrictor effects of angiotensin II on dorsal hand vein.
Sung, B.H. / Shah, K. / Kidambi, S. / Wilson, M.F. | 1999
99A-a
A010: Peculiarities of ischemic heart disease course in combination with essential hypertension.
Melnitsky, I.V. / Tashchuk, V.K. / Chaplinsky, R.B. / Polyanskaya, O.S. / Ilashchuk, I.I. | 1999
99A-b
A011: Angiotensin II induced greater venoconstriction in hypertensives
Vallabhan, T. / Sung, B.H. / Shah, K. / Kidambi, S. / Varadharajan, T. / Wilson, M.F. | 1999
99A-c
A012: Changes of lipid metabolism on condition of ischemic heart desease destabilization and essential hypertension.
Tashchuk, V.K. / Melnitsky, I.V. / Ilashchuk, I.I. | 1999
100A
A013: Renal vascular responses to captopril in healthy blacks: Vasodilation despite a high-salt intake.
Price, D.A. / Fisher, N.D.L. / Osei, S.Y. / Lansang, M.C. / Hollenberg, N.K. | 1999
100A-a
A014: Hypertensives exhibit enhanced pressor response to angiotensin II.
Sung, B.H. / Kidambi, S. / Vallabhan, T. / Shah, K. / Blum, R. / Wilson, M.F. | 1999
100A-b
A015: Arterial hypertension, myocardial infarction and obstructive pulmonary desease: Three-directed effect of irbesartan providing for optimum forming of postinfarction heart.
Vakalyuk, I.P. / Synoverska, O.B. / Byelogurov, P.L. | 1999
100A-c
A016: Irbesartan's influence on the forming of the connective cardiac matrix after myocardial infarction with hypertension.
Vakalyuk, I.P. / Byelogurov, P.L. / Nejko, E.M. / Seredyuk, N.M. | 1999
101A
A017: The association between polymorphism of renin-angiotensinogen genes and Chinese essential hypertensives
Wu, Kegui / Ye, Qiong / Zie, Liangdi | 1999
101A-a
A018: Central effects of AT1 receptor antagonism by eprosartan - in vitro autoradiography in the brain.
Muders, F. / Elsner, D. / Palkovits, M. / Riegger, GAJ. / Jandeleit, K. | 1999
102A
B001: Renal inducible NOS are responsible for the increased no synthesis in rats with high fructose diet.
Seculin, P. / Cosenzi, A. / Bernobich, E. / Plazzotta, N. / Bertola, G. / Galateo, C. / Bellini, G. | 1999
102A-a
B002: Role of enalapril (E) and diltiazem (DTZ) on tubulointerstitial lesions (TIL) in nephrotic rats (NR).
Toblli, J.E. / De Rosa, G. / Cao, G. / Angerosa, M. / Nyberg, C. | 1999
102A-b
B003: Angiotensin II-induced alterations in GTP-binding regulatory proteins in renal preglomerular arterioles from genetically hypertensive rats.
Vyas, S.J. / Blaschak, C.M. / Chinoy, M.R. / Jackson, E.K. | 1999
102A-c
B004: Role for glycation in the mecanism of renoprotection of calcium antagonist in Dahl salt hypertensive rat
Yamakado, M. / Taguchi, J. / Ohono, M. | 1999
103A
B005: Gonadal status and salt induced hypertension of the Sabra rat: Consequences in the distribution of renal {alpha}2-adrenoceptor subtypes
Ilhami, Norelyaqine / Khalid, Mostafa / Giudicelli, Yves / Dausse, Jean-Pierre | 1999
103A-a
B006: Hypertension in cafeteria fed rats: alteration in renal {alpha}2-adrenoceptor subtype
Coatmellec, G. / Ribière, C. / Giudicelli, Y. / Dausse, J.P. | 1999
103A-b
B007: A randomized and double blind comparison of isradipine, spirapril and their combination on decline in renal function in patients with chronic renal failure and hypertension.
Petersen, L.J. / Petersen, J.R. / Tallruphuus, U. / Møller, M.L. / Ladefoged, S.D. / Mehlsen, J. / Jensen, HÆ. | 1999
103A-c
B008: Renal perfusion in PTS with borderline hypertension (BH) based on Tc-DTPA transit renography.
Ivanov, M.V. | 1999
104A
B009: Renal perfusion determinants in PTS with borderline hypertension (BH).
Ivanov, M.V. | 1999
104A-a
B010: Serum uric acid (UA) and atherogenic lipides (AL) are nephrotoxic in PTS with essential hypertension (EH).
Ivanov, M.V. | 1999
104A-b
B011: Renal dopaminergic system participates in the natriuretic responses to acute sodium load in black salt-resistant but not in salt-sensitive subjects.
Damasceno, A. / Santos, A. / Pestana, M. / Serrão, P. / Soares-da-Silva, P. / Polónia, J. | 1999
104A-c
B012: Effects of fosinopril amlodipine combination on microalbuminuria in hypertensive patients with type 2 diabetes.
Zoppi, A. / Corradi, L. / Poletti, L. / Malamani, G.D. / Lazzari, P. / Preti, P. / Mugellini, A. / Pesce, R.M. / Fogari, R. | 1999
105A
B013: Comparable long-term renoprotection of amlodipine to ACE inhibitors in patients with moderate to severe renal dysfunction.
Kumagai, H. / Hayashi, K. / Kumamaru, H. / Saruta, T. | 1999
105A-a
B014: Comparison of prograf and neoral immunosuppression on plasma and urinary angiotensin peptides in adult kidney transplant recipients
Rohr, M.S. / Marterre, W.F. / Ferrario, C.M. / Yunis, C. / Brosnihan, K.B. | 1999
105A-b
B015: Apparent mineralocorticoid excess and pregnancy
Tedde, R. / Pala, A. / Lai, R. | 1999
105A-c
B016: Effects of treatment with ramipril on elderly patients with diabetes mellitus and albuminuria -
Zottola, C. / Mazzei, B. / Pranno, L. / Cundari, E. / Corsonello, A. / Gaudio, G. / Fiorentino, C. / Corsonello, F. | 1999
106A
B017: Quantitation of renal plasma flow with stage progress of essential hypertension using 99mTc-MAG3
Mukai, M. / Okuda, Y. / Konishi, S. / Takatsugi, K. / Matsuzaki, K. / Murakami, E. | 1999
107A
C001: Central blood pressure effects of S 23515, a ligand highly selective for imidazoline receptors over {alpha}2-adrenoceptors.
Bruban, V. / Feldman, J. / Jarry, C. / Schann, S. / Greney, H. / Scalbert, E. / Renard, P. / Dontenwill, M. / Bousquet, P. | 1999
107A-a
C002: Spinal nicotinic receptors in the SHR model of genetic hypertension
Khan, I. / Printz, M. / Taylor, P. | 1999
107A-b
C003: Autonomic stress responses in genetic hypertension: Role of specific brain regions.
Palmer, A.A. / Printz, M.P. | 1999
107A-c
C004: Effect of repeated restraint stress on baroreceptor reflex sensitivity: Role of corticotropin-releasing factor.
Conti, L.H. / Shannon, M.H. / Printz, M.P. | 1999
108A
C005: The release of acetylcholine and its dopaminergic regulation in the central nervous system of spontaneously hypertensive rats
Tsuda, K. / Kinoshita, Y. / Nishio, I. / Masuyama, Y. | 1999
108A-a
C006: Systolic and diastolic dysfunction in patients with diabetic autonomic neuropathy
Milovanovic, B. / Krotin, M. / Milovanovic, A. / Bisenic, V. / Zivanovic, B. / Vidric, D. / Veljovic, A. / Babic, M. | 1999
108A-b
C007: A major gender difference in the relation between adiposity and sympathetic activity in African-Americans.
Mansour, Y. / Abate, N. / Chavoshan, B. / Howell-Stampley, T. / Kizilbash, A. / Pollok, K. / Arbique, D. / Victor, R.G. | 1999
108A-c
C008: Effectiveness of propranolol in preventing vasovagal syncope in young men with primary hypertension
Di Girolamo, E. / Di Iorio, C. / Sabatini, P. / Leonzio, L. / Barsotti, A. | 1999
109A
C009: Peculiarities of heart rate reaction to passive head-up tilt and carotid baroreceptor reflex activation in patients with essential hypertension
Klincare, D. / Vitols, A. | 1999
109A-a
C010: Hyperthyroidism sinus tachycardia. Sympathetic stimulation or vagal inhibition?
Freitas, J. / Medina, J.L. / Santos, R.M. / Carvalho, M.J. / Costa, O. / Falcão de Freitas, A. | 1999
109A-b
C011: Changes in blood pressure and heart rate variability during dental surgery in essential hypertensives.
Miura, K. / Matsumura, K. / Nakamura, Y. / Kurokawa, H. / Yamashita, M. / Kajiyama, M. / Takata, Y. | 1999
109A-c
C012: Relationship between urinary catecholamines, ambulatory blood pressure, and microalbuminuria in hypertensive patients.
Gaudio, G. / Guasti, L. / Broggi, R. / Colombo, S. / Diolisi, A. / Garganico, D. / Grandi, A.M. / Bertolini, A. / Venco, A. | 1999
110A
C013: Heart rate and blood pressure variability in normotensive offspring of hypertensive subjects
Piccirillo, G. / Nocco, M. / Tarantini, S. / Lionetti, M. / Marigliano, V. | 1999
110A-a
C014: Hypertension and 1/f behavior of heart rate variability
Marcheselli, A. / Lino, S. / Strano, S. / Ferrucci, A. / Ciavarella, G.M. / Mazzei, A. / Calcagnini, G. | 1999
111A
D001: The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats
Huang, Wein-Pin / Chan, Paul / Cheng, Juei-Tang | 1999
111A-a
D002: A double-blind placebo-controlled study of the effectiveness and safety of oral stevioside in human hypertension
Liu, Ju-Chi / Chan, Paul / Cheng, Juei-Tang | 1999
111A-b
D003: Bosentan reduces blood pressure and the renal damage induced by high fructose diet in rats
Cosenzi, A. / Bernobich, E. / Plazzotta, N. / Seculin, P. / Bonavita, M. / Costacurta, C. / Bellini, G. | 1999
111A-c
D004: Bosentan reduces the deposition of collagen III in the left ventricle of rats with hypertension induced by high fructose diet
Plazzotta, N. / Cosenzi, A. / Bernobich, E. / Seculin, P. / Bonavita, M. / Guidone, B. / Bellini, G. | 1999
112A
D005: Hemodynamic effects of quinapril in hypertension
Kumar, N. / McAlister, N.H. | 1999
112A-a
D006: In vivo blockade of angiotensin II receptor binding in rat kidney: comparison of candesartan cilexetil with losartan
Fabiani, M.E. / Dinh, D.T. / Nassis, L. / Johnston, C.I. | 1999
112A-b
D007: Effect of losartan on human platelet activation
Guerra, J.I. / Montón, M. / Rodriguez-Feo, J.A. / Jiménez, A.M. / González-Fernández, F. / Bellver, T. / Rico, L. / García, R. / Gómez, J. / Farré, J. et al. | 1999
112A-c
D008: Doxazosin modifies Bcl-2 and Bax protein expression in the left ventricle of spontaneously hypertensive rats
Rodríguez-Feo, J.A. / González-Fernández, F. / Guerra, J.I. / Jiménez, A. / Aceituno, E. / Arriero, M.M. / Ayala, R. / Farré, J. / García, R. / Rico, L. et al. | 1999
113A
D009: Eplerenone lessens blood pressure elevation in non-salt-loaded stroke-prone hypertensive rats
Stier, Charles T. / Chander, Praveen N. / Mullen, David / Lesnik, Gregory / Rocha, Ricardo | 1999
113A-a
D010: Effects of metformin on arterial vascular sympathetic nerve endings
Peuler, J.D. / Lee, J.M. | 1999
113A-b
D011: Isosorbide dinitrate spray (IDS) is better than isosorbide dinitrate tablets (IDT) in the treatment of hypertensive emergencies (HE)
Rubio G, A.F. / Vargas A, G. / Narvaez R, J.L. / Lozano N, J.J. / Rodriguez L, L. / Trejo O, N. / Castro S, D. | 1999
113A-c
D012: Effect of cicletanine and its sulfo-conjugated metabolite on thiazide-sensitive Na-Cl cotransporter function
Gamba, G. / Droy-Lefaix, M.T. / Garay, R.P. | 1999
114A
D013: Gender differences in venodilatory effect of diltiazem in healthy normotensive individuals
Iqbal, M. / Khan, Z. / Shah, K. / Babar, M. / Sung, B.H. | 1999
114A-a
D014: S-nitrosocaptopril crystals preferentially decreases diastalic pressure in hypertensive rats
Lin, Mo-jun / Yang, XP / Wang, J / Jia, BJ | 1999
114A-b
D015: Soft analogs of bufuralol: initial pharmacologic evaluation
Juhasz, A. / Hwang, S.K. / Yoon, S.H. / Tatrai-Prokai, K. / Bodor, N. | 1999
114A-c
D016: Effects of nifedipine on blood pressure in patients with essential hypertension
Wang, Xi-Feng | 1999
115A
D017: Good clinical practices in monitoring antihypertensive clinical trials
Jett, C.M. | 1999
115A-a
D018: The influence of hypertension and antihypertensive drugs on 'new' cardiovascular risk factors, in dyslipidaemic patients
Papadakis, J.A. / Jagroop, I.A. / Nair, D.R. / Ganotakis, E.S. / Mikhailidis, D.P. / Winder, A.F. | 1999
115A-b
D019: Therapeutic effects of irbesartan in left ventricular hypertrophy
Feraco, E. | 1999
115A-c
D020: Irbesartan as monotherapy in older hypertensives
Feraco, E. | 1999
116A
D021: Influence of long-term losartan monotherapy on regress of myocardial hypertrophy and left ventricular function in renal parenchymal arterial hypertension
Sirenko, Yu. / Granich, V. / Radchenko, A. / Reiko, M. / Sidorenko, P. | 1999
116A-a
D022: The effect of antihypertensive therapy with amlodipine on the morning catecholamines, angiotensin- converting enzyme and insulin increments
Mishchenko, L. / Svishchenko, E. / Yarinkina, L. / Mkhytarian, L. | 1999
116A-b
D023: Valsartan, high BP reduction and hypertensive drive in human essential hypertension
Fariello, Raffaele / Crippa, Massimo / Notaristefano, Ilaria / Costa, Raffaella / Chiari, Ermanna | 1999
116A-c
D024: Treatment of hypertension with valsartan (V) alone or combined with spironolactone (S)
Leone, A. / Bertanelli, F. / Mori, L. | 1999
117A
D025: Long-term effects of losartan on hypertension and left ventricular mass in elderly patients
Tedesco, M.A. / Ratti, G. / Mennella, S. / Rainone, A.C. / Grieco, M. / Iarussi, D. / Iacono, A. | 1999
117A-a
D026: Subjective sleep quality during two different antihypertensive medications: Isradipine vs metoprolol
Kantola, I.M. / Rauhala, E. / Partinen, M. / Polo, O. / Ekman, K. / Kataja, M. / FISH Study Group, | 1999
117A-b
D027: Effect of nifedipine on urinary protein excretion in hypertensive patients
Crippa, G. / Sverzellati, E. / Antoniotti, P. / Carrara, G.C. | 1999
117A-c
D028: Diuresis responds slowly to antihypertensive formulations of the loop diuretic torasemide
Reyes, A.J. / Leary, W.P. | 1999
118A
D029: Classification of thirty-three formulations of diuretics by natriuretic potency
Reyes, A.J. / Leary, W.P. | 1999
118A-a
D030: Evaluation over 1 year of a new therapeutic strategy of perindopril 2mg/indapamide 0.625mg in the treatment of essential hypertension in subjects over the age of 65 years
Castaigne, A. / Chalmers, J. / Chastang, C. / Feldmann, L. / Guez, D. | 1999
118A-b
D031: Lacidipine as a monotherapy in treatment of hypertension with concomitant ischemic heart disease
Chumburidze, V.B. / Kurashvili, R.B. / Kikalishvili, T.T. / Khidasheli, T.J. / Akhobadze, T.I. / Nacopia, N.R. / Khelashvili, M.G. | 1999
118A-c
D032: Effects of different dihydropyyridine calcium antagonists on plasma norepinephrine in essential hypertension.
Fogari, R. / Corradi, L. / Zoppi, A. / Mugellini, A. / Preti, P. / Malamani, G.D. / Mennoia, V.N. / Finardi, G. | 1999
119A
D033: Ace-inhibition but not angiotensin II antagonism improves fibrinolysis and insulin sensitivity in hypertensive post-menopausal women.
Preti, P. / Banderali, A. / Zoppi, A. / Corradi, L. / Mugellini, A. / Pesce, R.M. / Fogari, R. | 1999
119A-a
D034: Combination therapy of calcium antagonists and ace inhibitors--the incidence of vasodilatory edema
Messerli, F.H. / Feng, Z. / Gradman, A.H. | 1999
119A-b
D035: Postmarketing surveillance study of amlodipine in hypertensive patients with hypertension not controlled with other antihypertensive agents. (Preliminary results)
Gil, A. / Jiménez, R. / González, M. / San Martin, M. / Becerril, E. / Vega, A. / Espejo, J. | 1999
119A-c
D036: In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor
Burrell, L.M. / Rockell, M.D. / Powell, J. / Johnston, C.I. | 1999
120A
D037: Influence of AT-1 receptor blockade on endothelium - derived factors in essential hypertension.
Cottone, S. / Vella, M.C. / Neri, A.L. / Vadalà, A. / Riccobene, R. / Cerasola, G. | 1999
120A-a
D038: Inhibition of sympathetic activity induced by losartan in essential hypertensives.
Cottone, S. / Neri, A.L. / Vella, M.C. / Vadalà, A. / Riccobene, R. / Cerasola, G. | 1999
120A-b
D039: Irbesartan safety and effectiveness: a post-marketing surveillance study
Bays, H.E. / Park, J.S. / Reilly, K. / Triscari, J. / AST investigators, | 1999
120A-c
D040: Long term efficacy, safety, and tolerability of candesartan cilexetil added to hydrochlorothiazide in patients with severe systemic hypertension
Oparil, Suzanne / Michelson, Eric L. / Candesartan Cilexetil Study Investigators, | 1999
121A
D041: Comparative effects of Candesartan Cilexetil and Losartan in systemic hypertension
Gradman, Alan H. / Michelson, Eric L. | 1999
121A-a
D042: Vasodilatory edema: synergistic effect of high-dose calcium antagonist/ace inhibitor combination therapy.
Messerli, F.H. / Feng, Z. / Michalewicz, L. | 1999
121A-b
D043: Raised aldosterone to renin ratio predicts anti-hypertensive efficacy of spironolactone. A prospective cohort follow-up study.
Lim, P.O. / Jung, R.T. / MacDonald, T.M. | 1999
121A-c
D044: Efficacy and tolerability of combination therapy in intensive blood pressure lowering - experience from the hot study.
Carruthers, George / Ruilope, Luis M. / HOT Study investigators, | 1999
122A
D046: Antihypertensive dose response of Omapatrilat, a vasopeptidase inhibitor, in mild to moderate hypertension
Weber, M.A. / Chang, P.I. / Reeves, R.A. / Moulton, K. / Pouleur, H. | 1999
122A-a
D047: Design and methods for the evaluation of Eprosartan in patients with isolated systolic hypertension
Black, H.R. / White, W.B. | 1999
122A-b
D048: Pediatric use of ace-inhibitors - a review from 1979 to 1996
Heintz, B. / Mertens, P. / Stefanidis, I. / Verho, M. | 1999
123A
D049: Effect of propranolol on muscle blood supply, energy metabolism, potassium ion balance and fatigue resistance at local static exercise in long-term antihypertensive treatment.
Vitols, A. / Liepina, D. | 1999
123A-a
D050: Characteristics of patients most likely to be treated in compliance with JNC-VI recommendations
Denton, Gerald D. / Smith, John / Faust, Joanne / Holmboe, Eric | 1999
123A-b
D051: Potential for use of pulse wave analysis in determining the interaction between Sildenafil and glyceryl trinitrate
O'Rourke, M. | 1999
123A-c
D052: Dose-response of the combination of irbesartan and hydrochlorothiazide in hypertensive patients.
Guthrie, R. / Weber, M. / Plat, F. | 1999
124A
D053: Lack of pharmacokinetic interaction between valsartan, an angiotensin II receptor blocker, and digoxin, a cardiotonic agent
Prasad, P. / Mangat, S. / Yeh, C.M. / Glazer, R. | 1999
124A-a
D054: Antihypertensive efficacy of Omapatrilat, a vasopeptidase inhibitor, compared with lisinopril.
Neutel, J. / Shepherd, A. / Pool, J. / Levy, E. / Saini, R. / Chang, P.I. | 1999
124A-b
D055: Safety and efficacy of nicardipine (NC) for hypertensive emergencies in children (CH)
Flynn, J.T. / Mottes, T.A. / Kershaw, D.B. / Smoyer, W.E. / Bunchman, T.E. | 1999
124A-c
D056: Amlodipine provides effective blood pressure (BP) control in children with primary or secondary hypertension (HTN)
Flynn, J.T. / Smoyer, W.E. / Bunchman, T.E. | 1999
125A
D057: How does the CA antagonist influence the relationship between blood pressure and physical activity by treating on short acting or long acting one?
Kakinoki, S. / Nomura, A. / Takechi, S. / Kitabatake, A. | 1999
125A-a
D058: Treatment of post-transplant erythrocytosis (PTE) with angiotensin-converting enzyme inhibitor (ACEi)
Pabico, R.C. / McKenna, B.A. / Yoo, K. / O'Mara, R. / Byer, B. / Yarger, J. / Kremer, M. / Monaghan, J. / Erturk, E. / Orloff, M. et al. | 1999
125A-b
D059: The safety and 24-hour antihypertensive efficacy of the vasopeptidase inhibitor Omapatrilat: a pilot study
Ruddy, M. / Guthrie, R. / Papademetriou, V. / Moulton, K. / Saini, R. | 1999
125A-c
D060: Efficacy and safety of Omapatrilat, a vasopeptidase inhibitor
Zusman, R. / Atlas, S. / Kochar, M. / Adler, E. / Levy, E. | 1999
126A
D061: Additional antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril
Pierdomenico, S.D. / Bucci, A. / Costantini, F. / Cipollone, F. / Cuccurullo, F. / Mezzetti, A. | 1999
126A-a
D062: Reduction in visual symptoms during antihypertensive monotherapies with long-acting calcium antagonists
Hernández-Hernández, R. / Armas-Hernández, M.J. / Velasco, M. / LASTLHY Steering Committee, | 1999
126A-b
D063: Efficacy and tolerability of the combination of Candesartan cilexetil and hydrochlorothiazide in systemic hypertension
Papademetriou, V. / Michelson, E.L. | 1999
126A-c
D064: Tolerability and antihypertensive efficacy of valsartan over 24 hours compared to nifedipine retard
Martínez, F. / Oigman, W. / Carrillo, J. Parra / Michieletto, L. / Valsartan Latam Investigators Group (VLIG), | 1999
127A
D065: Reduced diuretic-induced hypokalemia with valsartan in combination with HCTZ
Black, H. / Graff, A. / Glazer, R. / Shi, Y. | 1999
127A-a
D066: Superior tolerability of valsartan compared to captopril in asiatic patients
Lee, C.M. / Lee, Y.T. / Lang, M.G. / Prabowo, P. / Oddou-Stock, P. | 1999
127A-b
D067: Long-term efficacy and safety of valsartan in 823 mild to moderate hypertensives
Bremner, A. / Oddou-Stock, P. / Chrysant, S. / Marbury, T. / Feliciano, N. / Hester, A. / Cheng, H. | 1999
128A
D068: The antihypertensive efficacy and safety of Irbesartan compared with amlodipine for the treatment of mild-to-moderate hypertension.
Neutel, J. / Germino, W. / Smith, D. / Park, J-S. / Reilly, K. / Triscari, J. | 1999
128A-a
D070: Prognosis of elderly hypertensive patients in Japan
Hiwada, K. / Kohara, K. / Ogihara, T. / Matsumoto, M. / Matsuoka, H. / Shimamoto, K. / Takishita, S. / Toba, K. / Abe, I. | 1999
128A-b
D071: Antihypertensive drugs versus cardiovascular risk factors: the Zimbabwean experience
Ojewole, John A.O. / Kambarami, Runyararo M | 1999
129A
D072: Influence of the combination of verapamil and trandolapril on cardiovascular risk factors in patients with hypertension
Muñoz-Parra, F. / Gil-Extremera, B. / Maldonado-Martín, A. / Ruíz-López, M.F. / Huertas-Hernández, F. / León-Espinosa, M.T. / Ceballos-Atienza, R. / Cobo-Martínez, F. / Cruz-Benayas, M.A. / Castillo-Garzón, M.J. | 1999
129A-a
D073: Blood pressure and metabolic syndrome in essential hypertensive patients treated with losartan or verapamil after oral magnesium supplement.
Ruiz-López, M.F. / Gil-Extremera, B. / Maldonado-Martín, A. / Huertas-Hernández, F. / Ceballos-Atienza, R. / Muñoz-Parra, F. / Cruz-Benayas, M.A. / León-Espinosa-Monteros, M.T. / Cobo-Martínez, F. / Soto-Mas, J.A. | 1999
129A-b
D074: Let's stop using sublingual nifedipine now!
Ceballos-Atienza, R. / Extremera, B Gil / Martín, A Maldonado / Ruíz-López, M.F. / Huertas-Hernández, F. / Muñoz-Parra, F. / Cruz-Benayas, M.A. / Cano-Parra, M.D. / Martí-Canales, J.C. / Castillo-Garzón, M.J. | 1999
129A-c
D075: Objective monitoring of drug compliance: an important step in the management of hypertension resistant to drug therapy.
Burnier, M. / Schneider, M.P. / Chioléro, A. / Fallab, C.L. / Brunner, H.R. | 1999
130A
D076: Comparison of the angiotensin II receptor blockade induced by tasosartan and its active metabolite enoltasosartan in healthy subjects.
Rossat, J. / Maillard, M. / Brunner, H.R. / Burnier, M. | 1999
130A-a
D077: Evaluation of the interaction of tasosartan and enoltasosartan with plasma proteins using an angiotensin II receptor binding assay.
Maillard, M. / Rossat, J. / Centeno, C. / Brunner, H.R. / Burnier, M. | 1999
130A-b
D078: Improved short-term blood pressure control by treatment with calcium antagonists in patients with mild to moderate hypertension.
Lefrandt, J.D. / Urbigkeit, A. / Sevre, K. / Castellano, M. / Hausberg, M. / Fallon, M. / Fluckiger, L. / Heitmann, J. / Rostrup, M. / Rosei, E Agabiti et al. | 1999
130A-c
D079: Differential therapy by sectral and ednit in patients with arterial hypertension.
Binderis, N. / Kologrivova, L. / Mordovin, V. | 1999
131A
D080: Effects of ACE-inhibitors on the vegetative tone of the cardiovascular system in hypertensive patients
Konyaeva, E.B. / Agulova, L.P. / Kologrivova, L.V. / Mordovin, V.F. | 1999
131A-a
D081: Reduced heart rate during mental stress in hypertensive patients treated with verapamil compared to amlodipine.
Sevre, K. / Lefrandt, J.D. / Rostrup, M. / Smit, A.J. | 1999
131A-b
D082: Effects of valsartan on 24H ambulatory blood pressure monitoring
Ascioti, C. / Ferlaino, G. | 1999
131A-c
D083: Valsartan in the treatment of mild to moderate hypertension
Ascioti, C. / Ferlaino, G. | 1999
132A
D084: Lercanidipine in the treatment of mild to moderate hypertension.
Ascioti, C. / Ferlaino, G. | 1999
132A-a
D085: Treatment with doxazosin in hypertensive patients with dyslipidemia in Primary Care Centers.
Celorrio, J.M. / Jimenez, R. / Ansede, J.C. / Gil, A. | 1999
132A-b
D086: Beta blocker/HCTZ combination is superior to beta blocker alone in black patients with mild to moderate hypertension.
Radevski, I.V. / Valtchanova, Z.P. / Candy, G.P. / Tshele, E. / Sareli, P. | 1999
132A-c
D087: Quinapril/HCTZ combination rather than low-dose HCTZ should be recommended as first line antihypertensive therapy in black patients with mild to moderate hypertension.
Radevski, I.V. / Valtchanova, Z.P. / Candy, G.P. / Hopley, M. / Tshele, E. / Sareli, P. | 1999
133A
D088: Indapamide rather than low-dose HCTZ should be recommended as first line diuretic therapy in black patients with mild to moderate hypertension.
Radevski, I.V. / Valtchanova, Z.P. / Candy, G.P. / Tshele, E. / Ngcezula, T. / Sareli, P. | 1999
133A-a
D089: Differential effects of long acting ACE inhibitor and long acting calcium antagonist on ambulatory blood pressure in elderly hypertensive patients with different nocturnal BP fall
Eguchi, K. / Kario, K. / Shimada, K. | 1999
133A-b
D090: The effect of ACE inhibitors (A), {beta} blockers (B), Ca blockers (C) and diuretics (D) on untreated people with systolic hypertension
Morgan, T. / Anderson, A. / Lauri, J. / MacInnis, R. | 1999
133A-c
D091: Degree of diastolic blood pressure control among emergency department patients is not influenced by drug class of chronic antihypertensive medication.
Johns, C.D. / Geraci, S.A. / Schieginger, B. / Wesley, T.T. / Munir, A. / Blaho, K. | 1999
134A
D092: Indomethacin does not increase BP in hypertensive patients treated with amlodipine
Morgan, T. / Anderson, A. / Bertram, D. / Jones, E. | 1999
134A-a
D093: Beta blockers and serum potassium levels in hemodialysis patients.
Dunlay, R.W. / Frock, J.T. | 1999
134A-b
D094: The efficacy and safety of irbesartan in patients with essential hypertension in community hospitals of Catalonian
Felip, A. / Sobrino, J. / Plana, J. / Soler, J. / Ribera, L. / Adrián, M.J. / Módol, J. / Mínguez, A. / Esqué, J. / Pladevall, M. et al. | 1999
134A-c
D095: Use of Angiotensin (AII) antagonist losartan in patient treated with DSC LDL-apheresis.
Maxia, P. / Pintus, S. / Bianco, A. / Pintus, P. / Sanna, A. | 1999
135A
D096: A comparison of the inhibitory effects of candesartan cilexetil, losartan and valsartan on the response to angiotensin II infusion in hypertensive patients
Fridman, Katarina / Wysocki, Marian / Friberg, Peter / Andersson, Ove | 1999
135A-a
D097: Antihypertensive efficacy and safety of verapamil SR/trandolapril (240/2 mg) in patients insufficiently pretreated with verapamil SR 240 mg monotherapy.
Sever, P.S. / de Chatel, R. / Cifkova, R. / Sznajderman, M. / Notter, T. / Zilles, P. | 1999
135A-b
D098: Antihypertensive efficacy and effect on the left ventricular mass of losartan and trandolapril in patients with essential hypertension.
Valvo, E.V. / Stornello, M. / Canonico, G. / Di Pasquale, P. / Mossuti, E. | 1999
135A-c
D099: Enalapril versus valsartan at old patients: 24-hour antihypertensive efficacy and influence on quality of life
Nedogoda, S. / Chalabi, T. / Marchenko, I. / Butrina, L. / Sanina, T.N. / V, Petrov | 1999
136A
D100: Antioxidant action of moexipril in postmenopausal women with arterial hypertension
Nedogoda, S. / Buvailik, E. / Zhelezkin, V. | 1999
136A-a
D101: Which ACE inhibitor is better for postmenopausal women with high blood pressure?
Nedogoda, S. / Petrov, V. / Zhelezkin, V. | 1999
136A-b
D102: Efficacy and tolerability of amlodipine in elderly patients with hypertension.
Mazzei, B. / Zottola, C. / Fiorentino, C. / Pranno, L. / Cundari, E. / Corsonello, A. / Gaudio, G. / Corsonello, F. | 1999
136A-c
D103: Integrated cardiac and metabolic effects of the beta-1-selective blocker nebivolol in physically active patients with essential hypertension.
Mainka, W. / Schillings, W. / Scheele, K. / Duperly, J. / Ohba, H. / Fallois, J.V. / Schramm, T. / Rost, R.E. / Predel, H.G. | 1999
137A
D104: Effects of felodipine ER 10 mg and nitrendipine 20 mg on 24-hour blood pressure, stress tests and autonomic nervous system in hypertensive patients
Marcheselli, A. / Ferrucci, A. / Strano, S. / Ciavarel, G.M. / Lino, S. / Calcagnini, G. | 1999
137A-a
D105: Advantages of combined use of losartan and enalapril in patients with mild arterial hypertension
Koval, S.N. / Wilson, D.M. / Maslyaeva, L.V. / Penkova, M.Yu. / Bilovil, A.N. / Starchenko, T.G. | 1999
137A-b
D106: Diuretic therapy and renal cell carcinoma--what is the true risk/benefit ratio?
Messerli, F.H. / Grossman, E. / Goldbourt, U. | 1999
137A-c
D107: The additional efficacy of the diuretic-calcium antagonist combination depends on the potency of the drug introduced in first place.
Damasceno, A. / Caupers, P. / Santos, A. / Rafik, A. / Polónia, J. | 1999
138A
D108: Choice of antihypertensive medications for black female patients by physician specialty and region
Leader, S. / Muhuri, P. | 1999
138A-a
D109: Coronary events in diabetic and non-diabetic subjects on calcium channel antagonists or other antihypertensive drugs.
Boumendil, E.F. / Mugnier, C. | 1999
138A-b
D110: Perindopril in elderly hypertensives
Grandinetti, O. / Muti, V. / Matrangolo, E. / De Marco, A. / Ortale, C. / Chiappetta, P. / Monizzi, D. / Mirabelli, F. / Cherchi, M. | 1999
138A-c
D111: Combination EDNYT and COZAAR in heart failure with metabolic syndrome X.
Orynchak, MA / Neiko, EM / Seredjuk, VN / Seredjuk, NM | 1999
139A
E001: Metformin as an option for the management of obese patients with stage 1 hypertension.
Rubio, A.F. / Vargas, G. / Rodriguez, L. / Lozano, J.J. / Ramos, L. / Montaño, R. / Granados, M. | 1999
139A-a
E002: Irbesartan and atorvastatin improves endothelial function in hypertensive and hypercholesterolemic men
Calvo, C. / Gude, F. / Mosquera, A. / Riveiro, A. / Paz, E. / Pérez-Leirós, P. | 1999
139A-b
E003: Efficacy over 1 year of a fixed low-dose combination of perindopril 2 mg/indapamide 0.625 mg in the treatment of isolated systolic hypertension in subjects aged over 65 years
Chalmers, J. / Castaigne, A. / Chastang, C. / Feldmann, L. / Guez, D. | 1999
139A-c
E004: In hypertensive women, candesartan cilexetil lowers blood pressure more effectively and is better tolerated than enalapril or a diuretic.
Malmqvist, K. | 1999
140A
E005: Usefulness of the loaned self-measurement equipment model for diagnosis and treatment adjustment during a clinical trial using valsartan
Calvo-Vargas, C.G. / Galarza, D. / García-Gutiérrez, C. / Asociación de Medicina Interna de México research group., | 1999
140A-a
E006: The efficacy and safety of zofenopril compared to amlodipine in patients with mild to moderate hypertension
Giusti, A. / Bertolotti, M. / Clark, W.I.C. / Harrison, F.J.J. / de la Motte, S. / Casini, A. | 1999
140A-b
E007: Losartan treatment of patients with isolated systolic hypertension.
Farsang, C. / Garcia-Puig, J. / Niegowska, J. / Quintero Baiz, A. / Vrijens, F. / Bortman, G. / Losartan ISH Trial Investigators Group, | 1999
140A-c
E008: Safety of adenosine pharmacologic stress testing in subjects with low systolic arterial pressure
Haji, S.A. / Alkoutami, G.S. / Movahed, A. | 1999
141A
E009: Baseline characteristics of the first 14,242 patients enrolled in the convince study.
Black, H.R. / Elliott, W.J. / Grandits, G. / Fakouhi, T.D. / CONVINCE Study Group, | 1999
141A-a
E010: ABCD-2V: Appropriate blood pressure control in diabetes--part 2 with valsartan
Schrier, R.W. / Estacio, R.O. / Jeffers, B.W. / Biggerstaff, S. / Krinsky, E. / Pincus, J.R. / Bedigian, M.P. | 1999
141A-b
E011: History of hypertension and causes of death after acute myocardial infarction.
Berton, G. / Cordiano, R. / Mormino, P. / Mbaso, S. / Pianca, S. / Guarnieri, G.L. / Pagliara, V. / Piccoli, G. / Cucchini, F. / Palatini, P. | 1999
141A-c
E012: Improvement in cognitive function during antihypertensive monopharmacotherapy with calcium antagonists
Alcocer, L. / Armas-Hernández, M.J. / Hernández-Hernández, R. / LASTLHY Steering Committee, | 1999
142A
E013: Non-dipping of blood pressure during sleep does not predict awake or exercise hemodynamics. The Zilot study.
Papademetriou, V. / Narayan, P. / Kokkinos, P. / Neutel, J. | 1999
142A-a
E014: One year of antihypertensive treatment in patients with LVH: The life study.
Kjeldsen, S.E. / Dahlöf, B. / Devereux, R.B. / Julius, S. / Beevers, G. / Faire, U. / Fyhrquist, F. / Ibsen, H. / Kristianson, K. / Pedersen, O.L. et al. | 1999
142A-b
E015: The value trial: Patients demographics and progress report.
Julius, S. / Brunner, H.R. / Hansson, L. / Heath, R. / Kjeldsen, S.E. / Laragh, J.H. / McInnes, G.T. / Weber, M.A. / Zanchetti, A. / VALUE Study Group, | 1999
142A-c
E016: Effects on ambulatory blood pressure of low-dose aspirin in treated hypertensive patients.
Palumbo, G. / Alli, C. / Avanzini, F. / Bertele', V. / Colombo, F. / Pangrazzi, I. / Roncaglioni, C. / Tognoni, G. / PPP-Hypertension Study Investigators, | 1999
143A
E017: Effects of vitamin E on ambulatory blood pressure in hypertensive patients.
Palumbo, G. / Alli, C. / Avanzini, F. / Bertele', V. / Colombo, F. / Pangrazzi, I. / Roncaglioni, C. / Tognoni, G. / PPP-Hypertension Study Investigators, | 1999